[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 93 of about 93
1. Singh R, Shameema S, Vijaya K, Kumar P: Mullerian adenosarcoma of the uterus with sarcomatous overgrowth. Clin Med Insights Case Rep; 2010;3:27-30

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mullerian adenosarcoma of the uterus with sarcomatous overgrowth.
  • BACKGROUND AND OBJECTIVES: Mullerian adenosarcoma is an uncommon variant of mixed mesodermal tumour of the uterus.
  • In view of the rarity of this tumor, it is mandatory to do extensive histologic sampling to identify areas of sarcomatous overgrowth before arriving at a diagnosis of mullerian adenosarcoma as the clinical course and management vary.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Surg Pathol. 1999 Jul;23(7):809-14 [10403304.001]
  • [Cites] Gynecol Oncol. 2001 Oct;83(1):89-94 [11585418.001]
  • [Cites] Pathol Int. 2001 Sep;51(9):735-8 [11696179.001]
  • [Cites] N Engl J Med. 2002 Jun 6;346(23):1832-3 [12050351.001]
  • [Cites] Eur J Gynaecol Oncol. 2003;24(6):565-8 [14658606.001]
  • [Cites] Cancer. 1981 Jul 15;48(2):354-66 [6263458.001]
  • [Cites] Am J Surg Pathol. 1989 Jan;13(1):28-38 [2535774.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1986 Dec;12(12):2127-30 [3793549.001]
  • [Cites] Obstet Gynecol. 1986 Mar;67(3):417-24 [3945454.001]
  • [Cites] Cancer. 1974 Oct;34(4):1138-49 [4371193.001]
  • [Cites] Eur J Obstet Gynecol Reprod Biol. 2005 Apr 1;119(2):253-4 [15808391.001]
  • (PMID = 21769251.001).
  • [ISSN] 1179-5476
  • [Journal-full-title] Clinical medicine insights. Case reports
  • [ISO-abbreviation] Clin Med Insights Case Rep
  • [Language] ENG
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC3046009
  • [Keywords] NOTNLM ; adenosarcoma / heterologous elements / uterus
  •  go-up   go-down


2. Farhat MH, Hobeika EM, Moumneh G, Nassar AH: Uterine mullerian adenosarcoma with sarcomatous overgrowth fatal recurrence within two weeks of diagnosis: a case report. J Med Case Rep; 2007;1:103

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Uterine mullerian adenosarcoma with sarcomatous overgrowth fatal recurrence within two weeks of diagnosis: a case report.
  • Mullerian adenosarcoma with sarcomatous overgrowth (MASO) is a rare variant of uterine sarcomas, associated with postoperative recurrence, metastases and a fatal outcome.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Eur J Obstet Gynecol Reprod Biol. 2005 Apr 1;119(2):253-4 [15808391.001]
  • [Cites] Gynecol Oncol. 2001 Oct;83(1):89-94 [11585418.001]
  • [Cites] Arch Gynecol Obstet. 2000 Sep;264(2):105-7 [11045336.001]
  • [Cites] Oncol Rep. 1998 Jul-Aug;5(4):939-44 [9625851.001]
  • [Cites] Int J Gynecol Pathol. 1992;11(2):75-88 [1316323.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1986 Dec;12(12):2127-30 [3793549.001]
  • [Cites] Obstet Gynecol. 1986 Mar;67(3):417-24 [3945454.001]
  • [Cites] Hum Pathol. 1990 Apr;21(4):363-81 [2156771.001]
  • [Cites] Cancer. 1981 Jul 15;48(2):354-66 [6263458.001]
  • [Cites] Ultrastruct Pathol. 1980 Apr-Jun;1(2):189-200 [7233581.001]
  • [Cites] Cancer. 1974 Oct;34(4):1138-49 [4371193.001]
  • [Cites] N Engl J Med. 2002 Jun 6;346(23):1832-3 [12050351.001]
  • [Cites] Pathol Int. 2001 Sep;51(9):735-8 [11696179.001]
  • [Cites] Gynecol Oncol. 2001 Nov;83(2):424-7 [11606111.001]
  • [Cites] Gynecol Oncol. 1998 Jan;68(1):8-13 [9454652.001]
  • (PMID = 17894881.001).
  • [ISSN] 1752-1947
  • [Journal-full-title] Journal of medical case reports
  • [ISO-abbreviation] J Med Case Rep
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2098769
  •  go-up   go-down


3. Duggal R, Nijhawan R, Aggarwal N, Sikka P: Mullerian adenosarcoma (heterologous) of the cervix with sarcomatous overgrowth: a case report with review of literature. J Gynecol Oncol; 2010 Jun;21(2):125-8

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mullerian adenosarcoma (heterologous) of the cervix with sarcomatous overgrowth: a case report with review of literature.
  • Mullerian adenosarcoma is a rare biphasic malignant neoplasm of the cervix characterized by an admixture of benign epithelial elements and a malignant sarcomatous stromal component, which may be either homologous or heterologous.
  • An aggressive variant of adenosarcoma, mullerian adenosarcoma with sarcomatous overgrowth (MASO) is extremely rare, with only two such cases being reported in the English literature to date.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Hum Pathol. 1990 Apr;21(4):363-81 [2156771.001]
  • [Cites] Am J Surg Pathol. 1989 Jan;13(1):28-38 [2535774.001]
  • [Cites] Cancer. 1974 Oct;34(4):1138-49 [4371193.001]
  • [Cites] J Clin Pathol. 2008 Sep;61(9):1041-4 [18552169.001]
  • [Cites] Gynecol Oncol. 2007 Apr;105(1):256-60 [17292949.001]
  • [Cites] Ups J Med Sci. 2007;112(1):67-72 [17578809.001]
  • [Cites] Int J Gynecol Cancer. 2004 Sep-Oct;14(5):1024-9 [15361219.001]
  • (PMID = 20613904.001).
  • [ISSN] 2005-0399
  • [Journal-full-title] Journal of gynecologic oncology
  • [ISO-abbreviation] J Gynecol Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Korea (South)
  • [Other-IDs] NLM/ PMC2895712
  • [Keywords] NOTNLM ; Heterologous / Mullerian adenosarcoma / Sarcomatous overgrowth / Uterine cervix
  •  go-up   go-down


Advertisement
4. Chheda N, Bolegave M, Shet T, Tongaonkar H: Recurrent mullerian adenosarcoma like tumor of seminal vesicle. Indian J Pathol Microbiol; 2010 Apr-Jun;53(2):342-4

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Recurrent mullerian adenosarcoma like tumor of seminal vesicle.
  • Adenosarcoma like tumor of the seminal vesicle is reported herein.
  • Adenosarcomas have a low grade recurrent malignant potential and should be recognized.
  • [MeSH-major] Adenosarcoma / diagnosis. Adenosarcoma / pathology. Seminal Vesicles / pathology. Urogenital Neoplasms / diagnosis. Urogenital Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20551553.001).
  • [ISSN] 0974-5130
  • [Journal-full-title] Indian journal of pathology & microbiology
  • [ISO-abbreviation] Indian J Pathol Microbiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] India
  • [Chemical-registry-number] 0 / Antineoplastic Agents
  •  go-up   go-down


5. Bhardwaj M, Batrani M, Chawla I, Malik R: Uterine primitive neuroectodermal tumor with adenosarcoma: a case report. J Med Case Rep; 2010;4:195

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Uterine primitive neuroectodermal tumor with adenosarcoma: a case report.
  • They occur as either pure primitive neuroectodermal tumors or admixed with neoplasms of mullerian origin.
  • CASE PRESENTATION: A case of uterine primitive neuroectodermal tumor with adenosarcoma in a 50-year-old Asian Indian woman is presented.
  • Merging imperceptibly with the neuroectodermal components were the areas of adenosarcoma.
  • CONCLUSION: To the best of our knowledge, this report represents the second case of a uterine primitive neuroectodermal tumor with an admixed adenosarcoma.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Histopathology. 1979 May;3(3):167-80 [468120.001]
  • [Cites] Hum Pathol. 1992 Oct;23(10):1120-9 [1328031.001]
  • [Cites] Hum Pathol. 1990 Apr;21(4):363-81 [2156771.001]
  • [Cites] Arch Gynecol Obstet. 2009 Feb;279(2):259-61 [18523790.001]
  • [Cites] Gynecol Oncol. 2007 Aug;106(2):427-32 [17572479.001]
  • [Cites] Arch Gynecol Obstet. 2008 Apr;277(4):345-8 [17823807.001]
  • [Cites] Am J Surg Pathol. 2008 Feb;32(2):219-28 [18223324.001]
  • [Cites] Gynecol Oncol. 2007 Aug;106(2):419-22 [17537492.001]
  • (PMID = 20584309.001).
  • [ISSN] 1752-1947
  • [Journal-full-title] Journal of medical case reports
  • [ISO-abbreviation] J Med Case Rep
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2913979
  •  go-up   go-down


6. Fatnassi R, Amri F: [Adenosarcoma of the uterus: a case report]. J Gynecol Obstet Biol Reprod (Paris); 2005 May;34(3 Pt 1):270-2
MedlinePlus Health Information. consumer health - Uterine Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Adenosarcoma of the uterus: a case report].
  • Adenosarcoma of the uterus has two components: a benign epithelial proliferation and a stromal sarcoma.
  • The purpose of this work was to report the clinical aspects and therapeutic modalities of an exceptional case of uterine adenosarcoma in a 15-year-old girl revealed by pelvic pain.
  • Histology of the mass confirmed the diagnosis of adenosarcoma of the uterus.
  • [MeSH-major] Adenosarcoma / diagnosis. Uterine Neoplasms / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16012388.001).
  • [ISSN] 0368-2315
  • [Journal-full-title] Journal de gynécologie, obstétrique et biologie de la reproduction
  • [ISO-abbreviation] J Gynecol Obstet Biol Reprod (Paris)
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  • [Chemical-registry-number] 0 / Antineoplastic Agents
  •  go-up   go-down


7. McCluggage WG: Mullerian adenosarcoma of the female genital tract. Adv Anat Pathol; 2010 Mar;17(2):122-9
MedlinePlus Health Information. consumer health - Uterine Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mullerian adenosarcoma of the female genital tract.
  • Mullerian adenosarcoma is an uncommon, but not rare, mixed tumor containing a neoplastic but benign or mildly atypical epithelial element and a sarcomatous, usually low-grade, stromal component.
  • The most common site is the uterine corpus but adenosarcoma also occurs in the cervix and ovary and more rarely in the vagina, fallopian tube, arising from peritoneal surfaces, or outside the female genital tract, for example in the intestine.
  • Characteristic histologic features include a low power "phyllodes-like" architecture with leaf-like projections lined by a variety of benign Mullerian type epithelia, sometimes with squamous metaplasia.
  • Using the World Health Organization definition, stromal mitotic activity of 2 or more per 10 high-power fields is required for a diagnosis of adenosarcoma but in practice the diagnosis is made with stromal mitotic activity less than this if the characteristic architecture and cambium layer is present.
  • Uterine adenosarcomas are, in general, low-grade neoplasms capable of local recurrence after polypectomy or hysterectomy and much less commonly distant metastasis.
  • Adenosarcoma may be confused with a variety of lesions and one of the main differential diagnoses is adenofibroma in which the stromal component is, by definition, morphologically benign.
  • As such, it has been suggested that all adenofibromas should be classified as adenosarcomas, albeit with low-malignant potential.
  • Ovarian adenosarcomas are much more likely to exhibit malignant behavior than their uterine counterparts, probably due to the lack of an anatomic barrier to peritoneal dissemination.
  • [MeSH-major] Adenosarcoma / pathology. Uterine Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20179434.001).
  • [ISSN] 1533-4031
  • [Journal-full-title] Advances in anatomic pathology
  • [ISO-abbreviation] Adv Anat Pathol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 39
  •  go-up   go-down


8. Shi Y, Liu Z, Peng Z, Liu H, Yang K, Yao X: The diagnosis and treatment of Mullerian adenosarcoma of the uterus. Aust N Z J Obstet Gynaecol; 2008 Dec;48(6):596-600
International Agency for Research on Cancer - Screening Group. diagnostics - A practical manual on visual screening for cervical neoplasia .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The diagnosis and treatment of Mullerian adenosarcoma of the uterus.
  • BACKGROUND: Adenosarcoma of the uterus is one of the rare types of gynaecological malignant tumours.
  • AIM: To improve the level of diagnosis and treatment of Mullerian adenosarcoma of the uterus.
  • METHODS: The medical data of nine patients with Mullerian adenosarcoma of the uterus who were treated from May 1995 to March 2006 in our hospital were analysed retrospectively.
  • The prognosis was better in early stage disease in young patients.
  • CONCLUSIONS: The most common symptom of adenosarcoma of the uterus is abnormal uterine bleeding.
  • [MeSH-major] Adenosarcoma / diagnosis. Mixed Tumor, Mullerian / diagnosis. Neoplasms, Germ Cell and Embryonal / diagnosis. Uterine Cervical Neoplasms / diagnosis. Uterine Neoplasms / diagnosis

  • MedlinePlus Health Information. consumer health - Cervical Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19133051.001).
  • [ISSN] 1479-828X
  • [Journal-full-title] The Australian & New Zealand journal of obstetrics & gynaecology
  • [ISO-abbreviation] Aust N Z J Obstet Gynaecol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Australia
  •  go-up   go-down


9. Manoharan M, Azmi MA, Soosay G, Mould T, Weekes AR: Mullerian adenosarcoma of uterine cervix: report of three cases and review of literature. Gynecol Oncol; 2007 Apr;105(1):256-60
International Agency for Research on Cancer - Screening Group. diagnostics - Histopathology and cytopathology of the uterine cervix - digital atlas .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mullerian adenosarcoma of uterine cervix: report of three cases and review of literature.
  • BACKGROUND: Mullerian adenosarcoma of the uterine cervix is a rare tumor seen in young women of reproductive age group.
  • CASE: We present three cases of adenosarcoma of the cervix presenting as cervical polyps and review the clinical and pathological features of these tumors.
  • CONCLUSION: Adenosarcoma of the cervix should be ruled out especially in women presenting with recurrent cervical polyps.
  • [MeSH-major] Adenosarcoma / pathology. Mixed Tumor, Mullerian / pathology. Uterine Cervical Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Cervical Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17292949.001).
  • [ISSN] 0090-8258
  • [Journal-full-title] Gynecologic oncology
  • [ISO-abbreviation] Gynecol. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


10. Han XY, Xiang Y, Guo LN, Sheng K, Wan XR, Huang HF, Pan LY: [Mullerian adenosarcoma of the uterus: A clinicopathologic analysis of 9 cases]. Zhonghua Zhong Liu Za Zhi; 2010 Jan;32(1):44-7
Hazardous Substances Data Bank. IFOSFAMIDE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Mullerian adenosarcoma of the uterus: A clinicopathologic analysis of 9 cases].
  • OBJECTIVE: To investigate the clinicopathologic features, diagnosis, treatment and prognosis of uterine mullerian adenosarcoma.
  • METHODS: The clinicopathological data of 9 cases of uterine mullerian adenosarcoma in PUMC hospital from January 2003 to February 2009 were retrospectively analyzed.
  • RESULTS: There were 6 uterine endometrial adenosarcomas and 3 cervical adenosarcomas.
  • The adenosarcoma was characterized by benign or atypical-appearing neoplastic glands within a sarcomatous stroma.
  • During the follow-up, 2 cases of uterine endometrial adenosarcoma recurred.
  • CONCLUSION: Uterine mullerian adenosarcoma is a rare tumor without specific clinical symptoms and signs.
  • Surgical excision is the main treatment strategy with a good prognosis in the early stage disease with complete removal of tumors.
  • The prognosis is poor in advanced adenosarcoma with sarcomatous overgrowth.
  • [MeSH-minor] Adenosarcoma / drug therapy. Adenosarcoma / pathology. Adenosarcoma / surgery. Adolescent. Adult. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Chemotherapy, Adjuvant. Cisplatin / therapeutic use. Etoposide / therapeutic use. Female. Follow-Up Studies. Humans. Hysterectomy / methods. Ifosfamide / therapeutic use. Middle Aged. Neoplasm Recurrence, Local. Neoplasm Staging. Retrospective Studies. Uterine Neoplasms / drug therapy. Uterine Neoplasms / pathology. Uterine Neoplasms / surgery. Young Adult

  • MedlinePlus Health Information. consumer health - Cervical Cancer.
  • International Agency for Research on Cancer - Screening Group. diagnostics - Histopathology and cytopathology of the uterine cervix - digital atlas .
  • Hazardous Substances Data Bank. CIS-DIAMINEDICHLOROPLATINUM .
  • Hazardous Substances Data Bank. ETOPOSIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20211067.001).
  • [ISSN] 0253-3766
  • [Journal-full-title] Zhonghua zhong liu za zhi [Chinese journal of oncology]
  • [ISO-abbreviation] Zhonghua Zhong Liu Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 6PLQ3CP4P3 / Etoposide; Q20Q21Q62J / Cisplatin; UM20QQM95Y / Ifosfamide; Adenosarcoma of the uterus; ICE protocol 1
  •  go-up   go-down


11. Buyukkurt S, Guzel AB, Gumurdulu D, Vardar MA, Zeren H, Sucu M: Mullerian adenosarcoma of the uterine cervix in an adolescent girl. J Pediatr Adolesc Gynecol; 2010 Feb;23(1):e13-5
International Agency for Research on Cancer - Screening Group. diagnostics - Histopathology and cytopathology of the uterine cervix - digital atlas .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mullerian adenosarcoma of the uterine cervix in an adolescent girl.
  • BACKGROUND: Cervical adenosarcoma is a rare gynecological tumor which is prone to recur locally.
  • A case of cervical adenosarcoma in a 14-year-old girl treated in order to preserve fertility.
  • Histological evaluation revealed adenosarcoma.
  • SUMMARY AND CONCLUSION: Adenosarcoma is a low malignant potential tumor of the female genital tract.
  • [MeSH-major] Adenosarcoma / pathology. Uterine Cervical Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Cervical Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 North American Society for Pediatric and Adolescent Gynecology. Published by Elsevier Inc. All rights reserved.
  • (PMID = 19643645.001).
  • [ISSN] 1873-4332
  • [Journal-full-title] Journal of pediatric and adolescent gynecology
  • [ISO-abbreviation] J Pediatr Adolesc Gynecol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


12. Taçkin S, Bozaci EA, Sönmezer M, Ekinci C, Ortaç F: Late recurrence of uterine Mullerian adenosarcoma as heterologous sarcoma: Three recurrences in 8 months increasing in number and grade of sarcomatous components. Gynecol Oncol; 2006 Apr;101(1):179-82
MedlinePlus Health Information. consumer health - Uterine Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Late recurrence of uterine Mullerian adenosarcoma as heterologous sarcoma: Three recurrences in 8 months increasing in number and grade of sarcomatous components.
  • BACKGROUND: Uterine Mullerian adenosarcoma (UMA) is a rare and low-grade variant of mixed mesodermal tumor.
  • [MeSH-major] Adenosarcoma / pathology. Mixed Tumor, Mullerian / pathology. Neoplasm Recurrence, Local / pathology. Uterine Neoplasms / pathology

  • Genetic Alliance. consumer health - Uterine sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16325895.001).
  • [ISSN] 0090-8258
  • [Journal-full-title] Gynecologic oncology
  • [ISO-abbreviation] Gynecol. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


13. Adedipe TO, Vine SJ: Mullerian adenosarcoma of the uterus: a rare neoplasm with a need for onco-fertility. Eur J Gynaecol Oncol; 2010;31(6):714-6
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mullerian adenosarcoma of the uterus: a rare neoplasm with a need for onco-fertility.
  • However at the second presentation, following a polypectomy, a diagnosis of low-grade mullerian adenocarcinoma of the uterine body was made.
  • [MeSH-major] Adenosarcoma. Uterine Neoplasms

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21319526.001).
  • [ISSN] 0392-2936
  • [Journal-full-title] European journal of gynaecological oncology
  • [ISO-abbreviation] Eur. J. Gynaecol. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  • [Chemical-registry-number] Adenosarcoma of the uterus
  •  go-up   go-down


14. Bagga R, Keepanasseril A, Srinivasan R, Dey P, Gainder S, Saha SC, Dhaliwal LK, Patel F: Adenosarcoma of the uterine cervix with heterologous elements: a case report and review of literature. Arch Gynecol Obstet; 2010 Apr;281(4):669-75
International Agency for Research on Cancer - Screening Group. diagnostics - Histopathology and cytopathology of the uterine cervix - digital atlas .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adenosarcoma of the uterine cervix with heterologous elements: a case report and review of literature.
  • INTRODUCTION: Adenosarcoma of the uterus is a rare tumor composed of benign epithelial and malignant stromal components, usually encountered in young women.
  • Till date, more than 100 cases of mullerian adenosarcoma of the cervix with homologous elements have been reported.
  • However, only 15 cases of mullerian adenosarcoma of the cervix with heterologous elements are reported.
  • MATERIALS AND METHODS: We describe a case of mullerian adenosarcoma with heterologous elements of rhabdomyosarcoma and benign cartilage presenting as a cervical polyp in a young girl.
  • CONCLUSION: Cervical adenosarcomas are rare tumors that may appear in reproductive age.
  • [MeSH-major] Adenosarcoma / pathology. Cervix Uteri / pathology. Uterine Cervical Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Cervical Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19685064.001).
  • [ISSN] 1432-0711
  • [Journal-full-title] Archives of gynecology and obstetrics
  • [ISO-abbreviation] Arch. Gynecol. Obstet.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Germany
  • [Number-of-references] 33
  •  go-up   go-down


15. Fleming NA, Hopkins L, de Nanassy J, Senterman M, Black AY: Mullerian adenosarcoma of the cervix in a 10-year-old girl: case report and review of the literature. J Pediatr Adolesc Gynecol; 2009 Aug;22(4):e45-51
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mullerian adenosarcoma of the cervix in a 10-year-old girl: case report and review of the literature.
  • Müllerian adenosarcoma is a rare neoplasm usually found in postmenopausal women.
  • We present a case of a 10-year-old girl who was diagnosed with müllerian adenosarcoma arising from the endocervix, the youngest female ever reported.
  • The final pathology revealed müllerian adenosarcoma, favoring an endocervical origin.
  • Pathology confirmed a diagnosis of müllerian adenosarcoma originating from the endocervix.
  • Clinically, there was no evidence of residual disease.
  • CONCLUSION: Müllerian adenosarcoma of the endocervix is a very rare pediatric tumor.
  • Chemotherapy and radiation have not been used in the absence of extensive pelvic and/or residual disease.
  • [MeSH-major] Adenosarcoma / pathology. Uterine Cervical Neoplasms / pathology


16. Chang HY, Changchien CC, Chen HH, Lin H, Huang CC: Extrauterine müllerian adenosarcoma associated with endometriosis and rectal villotubular adenoma: report of a case and review of the literature. Int J Gynecol Cancer; 2005 Mar-Apr;15(2):361-5
MedlinePlus Health Information. consumer health - Endometriosis.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Extrauterine müllerian adenosarcoma associated with endometriosis and rectal villotubular adenoma: report of a case and review of the literature.
  • Extrauterine mullerian adenosarcoma is rare and is thought to arise from endometriotic deposits or pluripotent mesothelial and mesenchymal cells of the pelvic cavity.
  • Concomitant colon-rectal neoplasm was reported but the relationship between extrauterine adenosarcoma and colon tumor was not studied.
  • We describe an extrauterine adenosarcoma with a concomitant rectal tubulovillous adenoma.
  • Immunohistochemical study was performed to investigate the origin and nature of the adenosarcoma.
  • Immunostaining provided the evidence to distinguish between rectal tumor and adenosarcoma.
  • Extrauterine adenosarcoma may arise from endometriosis, and hormone replacement therapy may have some role in the malignant transformation process.
  • Adenosarcoma should be considered in the differential diagnosis of a new pelvic tumor in a patient with a history of endometriosis.
  • [MeSH-major] Adenoma / complications. Adenosarcoma / etiology. Adenosarcoma / pathology. Endometriosis / complications. Neoplasms, Multiple Primary / pathology. Rectal Neoplasms / pathology

  • Genetic Alliance. consumer health - Endometriosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15823126.001).
  • [ISSN] 1048-891X
  • [Journal-full-title] International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
  • [ISO-abbreviation] Int. J. Gynecol. Cancer
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


17. Recinos-Money E, Escobar-Alfaro G, Contreras J, Zepeda-Castilla E, Parra-Torres C, Di Castro P: [Ovarian adenosarcoma with elevated CA125 antigen. Case report and literature review]. Cir Cir; 2008 Jan-Feb;76(1):71-5
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Ovarian adenosarcoma with elevated CA125 antigen. Case report and literature review].
  • [Transliterated title] Adenosarcoma de ovario asociado con elevación del antígeno sérico Ca-125. Informe de caso y revisión de literatura.
  • BACKGROUND: Adenosarcomas are rare tumors usually derived from the endometrium.
  • About 50 cases of adenosarcomas of the ovary have been reported.
  • The relationship between adenosarcoma and CA125 has not been described.
  • The authors present a case of adenosarcoma with elevated CA125 because of the unusual presentation of this pathology and also because elevation of the CA125 antigen has not been reported in the literature.
  • Histology revealed a homologous Müllerian adenosarcoma of the right ovary with sarcomatous overgrowth.
  • Sixteen months post-surgery, the patient is disease free and with normal CA125.
  • DISCUSSION: Ovarian adenosarcomas are more aggressive than adenosarcomas of the uterus.
  • Because of the embryological origin, ovarian adenosarcomas are able to produce CA125 antigen, especially in the presence of sarcomatous overgrowth.
  • CONCLUSIONS: CA125 may be useful for follow-up of ovarian adenosarcomas.
  • Elevated CA125 antigen in adenosarcomas of the ovary may be indicative of sarcomatous overgrowth and poor prognosis.
  • [MeSH-major] Adenosarcoma / blood. Biomarkers, Tumor / blood. CA-125 Antigen / blood. Ovarian Neoplasms / blood
  • [MeSH-minor] Adult. Antineoplastic Agents, Hormonal / therapeutic use. Chemotherapy, Adjuvant. Female. Humans. Hysterectomy. Incidental Findings. Lymph Node Excision. Medroxyprogesterone / therapeutic use. Mullerian Ducts / embryology. Omentum / surgery. Ovariectomy. Prognosis. Remission Induction

  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • Hazardous Substances Data Bank. MEDROXYPROGESTERONE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18492424.001).
  • [ISSN] 0009-7411
  • [Journal-full-title] Cirugía y cirujanos
  • [ISO-abbreviation] Cir Cir
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] Mexico
  • [Chemical-registry-number] 0 / Antineoplastic Agents, Hormonal; 0 / Biomarkers, Tumor; 0 / CA-125 Antigen; HSU1C9YRES / Medroxyprogesterone
  • [Number-of-references] 27
  •  go-up   go-down


18. Haj Salah MB, Mekni A, Ines C, Haha Bellil SB, Bellil K, Kchir N, Haouet S, Zaouari F, Zitouna M: [Endometrial adenosarcoma with rhabdomyoblastic differenciation]. Tunis Med; 2007 Oct;85(10):899-901

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Endometrial adenosarcoma with rhabdomyoblastic differenciation].
  • BACKGROUND: Mixed mullerian tumours are uncommon endometrial neoplasms that are composed by a combination of mesencymal elements and epithelial elements.
  • They own their denomination to the mullerian origin of their components wich derive from the paramesonephric ducts.
  • According to the benignity or the malignity of each component, four types of mixed mullerian tumours are individualised.
  • Adenosarcoma is composed of benign glandular elements and sarcomatous, usually low-grade, stromal elements.
  • AIM: We report a case of an endometrial adenosarcoma in a 59-year-old woman.
  • [MeSH-major] Adenosarcoma / diagnosis. Endometrial Neoplasms / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18236817.001).
  • [ISSN] 0041-4131
  • [Journal-full-title] La Tunisie médicale
  • [ISO-abbreviation] Tunis Med
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Tunisia
  •  go-up   go-down


19. Fleshman RL, Wasman JK, Bodner DG, Young RH, MacLennan GT: Mesodermal adenosarcoma of the testis. Am J Surg Pathol; 2005 Mar;29(3):420-3
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mesodermal adenosarcoma of the testis.
  • Biphasic neoplasms with a benign to atypical epithelial component and a usually low-grade malignant stromal component have been reported in various sites, probably being best known for their occurrence in the uterine corpus (mullerian adenosarcoma).
  • We report a tumor of this type that occurred in the testis of a 76-year-old man and, to our knowledge, is the first mesodermal adenosarcoma reported at this site.
  • This case expands the known sites where mesodermal adenosarcoma may occur.
  • [MeSH-major] Adenosarcoma / pathology. Mixed Tumor, Mesodermal / pathology. Testicular Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Testicular Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15725814.001).
  • [ISSN] 0147-5185
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Actins; 0 / Biomarkers, Tumor; 0 / Desmin; EC 3.4.24.11 / Neprilysin
  •  go-up   go-down


20. Milam MR, Atkinson JB, Currie JL: Adenosarcoma arising in inguinal endometriosis. Obstet Gynecol; 2006 Sep;108(3 Pt 2):753-5
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adenosarcoma arising in inguinal endometriosis.
  • BACKGROUND: Adenosarcoma arising in inguinal endometriosis is a rare clinical entity.
  • Surgical en bloc excision of the 12 x 4 cm inguinal mass revealed adenosarcoma arising in endometriosis.
  • CONCLUSION: Although a rare entity, adenosarcoma arising in inguinal endometriosis should be included in the differential diagnosis for those patients with a history of endometriosis and chronic unopposed estrogen therapy who present with a groin mass.
  • [MeSH-major] Adenosarcoma / diagnosis. Endometriosis / complications. Inguinal Canal

  • Genetic Alliance. consumer health - Endometriosis.
  • MedlinePlus Health Information. consumer health - Endometriosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17018491.001).
  • [ISSN] 0029-7844
  • [Journal-full-title] Obstetrics and gynecology
  • [ISO-abbreviation] Obstet Gynecol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


21. Chen ZW, Saad RS: Ovarian adenosarcoma arising from benign cystadenoma and associated intraoperative consultation pitfalls. Int J Gynecol Pathol; 2010 Sep;29(5):415-8
MedlinePlus Health Information. consumer health - Ovarian Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Ovarian adenosarcoma arising from benign cystadenoma and associated intraoperative consultation pitfalls.
  • An unusual case of ovarian adenosarcoma arising from a smooth-walled serous cystadenoma is described.
  • On the permanent sections, a phyllodes-like pattern of stromal proliferation and periglandular condensation of atypical stromal cells with a mitotic count of 3 per 10 high-power fields was more apparent and led to the diagnosis of adenosarcoma.
  • To our knowledge, this is the first reported case of an adenosarcoma arising from a grossly benign cystadenoma and the third case in the literature of an adenosarcoma associated with a cystadeno(fibro)ma.
  • This case also shows the challenges in differentiating adenosarcoma from a benign counterpart on both frozen and permanent sections.
  • [MeSH-major] Adenosarcoma / pathology. Cystadenoma / pathology. Neoplasms, Multiple Primary / pathology. Ovarian Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20736764.001).
  • [ISSN] 1538-7151
  • [Journal-full-title] International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
  • [ISO-abbreviation] Int. J. Gynecol. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


22. Takeuchi M, Matsuzaki K, Yoshida S, Kudo E, Bando Y, Hasebe H, Kamada M, Nishitani H: Adenosarcoma of the uterus: magnetic resonance imaging characteristics. Clin Imaging; 2009 May-Jun;33(3):244-7
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adenosarcoma of the uterus: magnetic resonance imaging characteristics.
  • Adenosarcoma of the uterus is a rare tumor containing benign glandular epithelial and malignant mesenchymal elements.
  • Typical adenosarcoma is a low-grade tumor, presents as a large polypoid mass occupying the endometrial cavity, and may protrude into the vaginal cavity.
  • [MeSH-major] Adenosarcoma / diagnosis. Magnetic Resonance Imaging / methods. Uterine Neoplasms / diagnosis. Uterus / pathology

  • MedlinePlus Health Information. consumer health - MRI Scans.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19411035.001).
  • [ISSN] 1873-4499
  • [Journal-full-title] Clinical imaging
  • [ISO-abbreviation] Clin Imaging
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


23. Arend R, Bagaria M, Lewin SN, Sun X, Deutsch I, Burke WM, Herzog TJ, Wright JD: Long-term outcome and natural history of uterine adenosarcomas. Gynecol Oncol; 2010 Nov;119(2):305-8
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Long-term outcome and natural history of uterine adenosarcomas.
  • OBJECTIVE: Adenosarcomas are rare tumors composed of a benign epithelium in combination with a malignant mesenchymal component.
  • We examined the natural history of uterine adenosarcomas and compared the outcome of uterine adenosarcoma and carcinosarcoma.
  • METHODS: Patients with uterine adenosarcomas and carcinosarcomas registered in the Surveillance, Epidemiology, and End Results database between 1988 and 2006 were examined.
  • RESULTS: A total of 5496 patients including 544 (10%) with adenosarcomas were identified.
  • Patients with adenosarcomas tended to be younger and were more likely to have early-stage tumors (p<0.0001) In a multivariate model patients with adenosarcomas were 65% (HR=0.35; 95% CI, 0.28-0.45) less likely to die from their tumors than women with carcinosarcomas.
  • Five-year survival was 79% (95% CI, 75-84%) for stage I adenosarcomas and 51% (95% CI, 49-54%) for carcinosarcomas.
  • For stage III disease, 5-year survival for adenosarcomas was 48% (95% CI, 29-65%) vs. 24% (95% CI, 20-27%) for carcinosarcomas.
  • CONCLUSION: The majority of women with uterine adenosarcoma present with early-stage tumors and have a favorable outcome.
  • Despite the overall favorable prognosis for most patients, survival is only 63-69% for women whose tumors invade into the wall of the uterus and lower than 50% for disease spread beyond the uterus.
  • [MeSH-major] Adenosarcoma / epidemiology. Adenosarcoma / pathology. Uterine Neoplasms / epidemiology. Uterine Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Elsevier Inc. All rights reserved.
  • (PMID = 20688363.001).
  • [ISSN] 1095-6859
  • [Journal-full-title] Gynecologic oncology
  • [ISO-abbreviation] Gynecol. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


24. Shetty M, Lal N, Vu NH: Müllerian adenosarcoma of the ovary: case report and review of the literature. Ultrasound Q; 2007 Sep;23(3):189-91
MedlinePlus Health Information. consumer health - Ovarian Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Müllerian adenosarcoma of the ovary: case report and review of the literature.
  • Müllerian adenosarcoma is a rare neoplasm that can arise in both uterine and extrauterine locations.
  • This report describes the ultrasound and magnetic resonance imaging findings of one case of ovarian adenosarcoma and reviews the literature as to the previously described imaging findings.
  • Adenosarcoma should be considered in patients with a predominantly solid pelvic mass on imaging, particularly in those with a history of endometriosis or findings compatible with endometriosis on ultrasound or magnetic resonance imaging.
  • [MeSH-major] Adenosarcoma / diagnosis. Mixed Tumor, Mullerian / diagnosis. Ovarian Neoplasms / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17805167.001).
  • [ISSN] 0894-8771
  • [Journal-full-title] Ultrasound quarterly
  • [ISO-abbreviation] Ultrasound Q
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 10
  •  go-up   go-down


25. González Bosquet E, Sunol M, Callejo J, Lailla JM: Uterine adenosarcoma diagnosed following hysteroscopic resection of an intrauterine tumour. Eur J Gynaecol Oncol; 2005;26(4):415-7
MedlinePlus Health Information. consumer health - Uterine Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Uterine adenosarcoma diagnosed following hysteroscopic resection of an intrauterine tumour.
  • Uterine adenosarcoma is a mixed müllerian tumour consisting of a benign epithelial component and a malignant stromal component.
  • The pathologic diagnosis of the tumour removed by hysteroscopy was uterine adenosarcoma.
  • [MeSH-major] Adenosarcoma / diagnosis. Hysteroscopy. Uterine Neoplasms / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16122191.001).
  • [ISSN] 0392-2936
  • [Journal-full-title] European journal of gynaecological oncology
  • [ISO-abbreviation] Eur. J. Gynaecol. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


26. Soslow RA, Ali A, Oliva E: Mullerian adenosarcomas: an immunophenotypic analysis of 35 cases. Am J Surg Pathol; 2008 Jul;32(7):1013-21
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mullerian adenosarcomas: an immunophenotypic analysis of 35 cases.
  • Mullerian adenosarcomas (MAs) are rare mixed mesenchymal and epithelial neoplasms that occur most commonly in the uterus.
  • Although the epithelial component is typically benign, the mesenchymal component of most adenosarcomas morphologically resembles that observed in endometrial stromal tumors and is responsible for their clinical behavior.
  • ER, PR, and CD10 expression was lost in MA-SOs relative to conventional low-grade stromal areas of mullerian/mesodermal adenosarcomas, reflecting the "dedifferentiation" of this component.
  • [MeSH-major] Adenosarcoma / pathology. Mixed Tumor, Mullerian / pathology. Uterine Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18469708.001).
  • [ISSN] 1532-0979
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


27. Geisler JP, Orr CJ, Manahan KJ: Robotically assisted total laparoscopic radical trachelectomy for fertility sparing in stage IB1 adenosarcoma of the cervix. J Laparoendosc Adv Surg Tech A; 2008 Oct;18(5):727-9
International Agency for Research on Cancer - Screening Group. diagnostics - Histopathology and cytopathology of the uterine cervix - digital atlas .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Robotically assisted total laparoscopic radical trachelectomy for fertility sparing in stage IB1 adenosarcoma of the cervix.
  • Adenosarcomas are rare cervical tumors with unknown optimal treatment, which often affects young women.
  • A 23-year-old woman was found to have a stage IB1 adenosarcoma of the cervix.
  • [MeSH-major] Adenosarcoma / surgery. Laparoscopy / methods. Robotics / instrumentation. Uterine Cervical Neoplasms / surgery

  • MedlinePlus Health Information. consumer health - Cervical Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18803518.001).
  • [ISSN] 1092-6429
  • [Journal-full-title] Journal of laparoendoscopic & advanced surgical techniques. Part A
  • [ISO-abbreviation] J Laparoendosc Adv Surg Tech A
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


28. Ozmen B, Uzum N, Unlu C, Ortac F, Ataoglu O: Surgical conservation of both ovaries in an adolescent with uterine müllerian adenosarcoma: a case report. J Minim Invasive Gynecol; 2007 May-Jun;14(3):375-8
MedlinePlus Health Information. consumer health - Uterine Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Surgical conservation of both ovaries in an adolescent with uterine müllerian adenosarcoma: a case report.
  • However, data on conservation of ovaries in uterine müllerian adenosarcoma are limited due to its very rare incidence in reproductive-aged females.
  • Conservation of both ovaries along with adjuvant chemotherapy was performed in a 14-year-old girl with uterine adenosarcoma.
  • After 30 months, she had no evidence of disease.
  • Therefore, surgical conservation of ovaries might be a solution for fertility sparing in uterine müllerian adenosarcoma.
  • [MeSH-major] Adenosarcoma / surgery. Mixed Tumor, Mullerian / surgery. Uterine Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17478375.001).
  • [ISSN] 1553-4650
  • [Journal-full-title] Journal of minimally invasive gynecology
  • [ISO-abbreviation] J Minim Invasive Gynecol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


29. Van Mieghem T, Abeler VM, Moerman P, Verbist L, Vergote I, Amant F: CD10, estrogen and progesterone receptor expression in ovarian adenosarcoma. Gynecol Oncol; 2005 Nov;99(2):493-6
MedlinePlus Health Information. consumer health - Ovarian Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] CD10, estrogen and progesterone receptor expression in ovarian adenosarcoma.
  • BACKGROUND: : The low incidence of ovarian adenosarcomas explains the paucity of available data regarding their biologic markers.
  • CASE: : Four cases of primary ovarian adenosarcoma were retrieved in our pathology databases.
  • We assessed the immunohistochemical stainings for ER, PR and CD10 in 3 ovarian adenosarcomas without sarcomatous overgrowth (OAS), and 1 ovarian adenosarcoma with sarcomatous overgrowth (OAS-S).
  • CONCLUSION: : The identification of a hormone sensitive disease is the main clinical implication of this study.
  • [MeSH-major] Adenosarcoma / metabolism. Neprilysin / biosynthesis. Ovarian Neoplasms / metabolism. Receptors, Estrogen / biosynthesis. Receptors, Progesterone / biosynthesis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16051333.001).
  • [ISSN] 0090-8258
  • [Journal-full-title] Gynecologic oncology
  • [ISO-abbreviation] Gynecol. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Receptors, Estrogen; 0 / Receptors, Progesterone; EC 3.4.24.11 / Neprilysin
  •  go-up   go-down


30. Pasternak S, MacIntosh R: Uterine adenosarcoma detected by Papanicolaou smear: a case report. Diagn Cytopathol; 2006 Jul;34(7):495-8
MedlinePlus Health Information. consumer health - Uterine Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Uterine adenosarcoma detected by Papanicolaou smear: a case report.
  • Adenosarcoma is a rare uterine biphasic tumor composed of benign epithelial elements and a sarcomatous stroma.
  • We describe a case of uterine adenosarcoma that was first detected by Papanicolau (Pap) smear.
  • Adenosarcomas are rare lesions but should be considered in the differential diagnosis when spindled cells are noted in a pap smear.
  • [MeSH-major] Adenosarcoma / pathology. Papanicolaou Test. Uterine Neoplasms / pathology. Vaginal Smears

  • MedlinePlus Health Information. consumer health - Cervical Cancer Screening.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2006 Wiley-Liss, Inc.
  • (PMID = 16783778.001).
  • [ISSN] 8755-1039
  • [Journal-full-title] Diagnostic cytopathology
  • [ISO-abbreviation] Diagn. Cytopathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


31. Comunoğlu N, Comunoğlu C, Başsüllü N, Somunkiran A, Calay Z: Müllerian adenosarcoma with sarcomatous overgrowth of the cervix: unusual large polypoid mass. Ups J Med Sci; 2007;112(1):67-72
International Agency for Research on Cancer - Screening Group. diagnostics - A practical manual on visual screening for cervical neoplasia .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Müllerian adenosarcoma with sarcomatous overgrowth of the cervix: unusual large polypoid mass.
  • Müllerian adenosarcoma (MS) is a rare neoplasm of uterine cervix composed of benign epithelial and malignant stromal components.
  • An aggressive variant of adenosarcoma, müllerian adenosarcoma with sarcomatous overgrowth (MASO) is extremely rare.
  • The patient has been clinically free of disease for 14 months of follow up after total abdominal hysterectomy and bilateralsalpingo-oopherectomy.
  • [MeSH-major] Adenosarcoma / diagnosis. Mixed Tumor, Mullerian / diagnosis. Uterine Cervical Neoplasms / diagnosis


32. Manipadam MT, Munemane A, Emmanuel P, McCluggage WG: Ovarian adenosarcoma with extensive deciduoid morphology arising in endometriosis: a case report. Int J Gynecol Pathol; 2008 Jul;27(3):398-401
MedlinePlus Health Information. consumer health - Ovarian Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Ovarian adenosarcoma with extensive deciduoid morphology arising in endometriosis: a case report.
  • A case of müllerian adenosarcoma arising in ovarian endometriosis is reported in which the whole of the mesenchymal component exhibited striking deciduoid morphology, a phenomenon that has not been previously described.
  • [MeSH-major] Adenosarcoma / pathology. Endometriosis / pathology. Ovarian Neoplasms / pathology

  • Genetic Alliance. consumer health - Endometriosis.
  • MedlinePlus Health Information. consumer health - Endometriosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18580317.001).
  • [ISSN] 1538-7151
  • [Journal-full-title] International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
  • [ISO-abbreviation] Int. J. Gynecol. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


33. Sakr R, Marzouk P, Bricou A, Demaria F, Cortez A, Benifla JL: Uterine adenosarcoma associated to lymphovascular emboli: a case report. Cases J; 2009;2:7515

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Uterine adenosarcoma associated to lymphovascular emboli: a case report.
  • INTRODUCTION: Uterine adenosarcoma is a rarely observed polypoid tumor with a mixed benign epithelial element and malignant stromal component.
  • Finally, a total abdominal hysterectomy was performed because of atypical cells and suspected uterine adenosarcoma.
  • The hysterectomy specimen confirmed the presence of uterine adenosarcoma associated with lymphatic and vascular tumor emboli.
  • CONCLUSION: In our report, we present a case of uterine adenosarcoma which was diagnosed after multiple surgical procedures and associated to lymphovascular emboli known to have a significant impact on overall survival and distant metastasis-free survival.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Clin Otolaryngol Allied Sci. 1976;1(1):17-26 [1031337.001]
  • (PMID = 19829987.001).
  • [ISSN] 1757-1626
  • [Journal-full-title] Cases journal
  • [ISO-abbreviation] Cases J
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2740208
  •  go-up   go-down


34. Gallardo A, Prat J: Mullerian adenosarcoma: a clinicopathologic and immunohistochemical study of 55 cases challenging the existence of adenofibroma. Am J Surg Pathol; 2009 Feb;33(2):278-88
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mullerian adenosarcoma: a clinicopathologic and immunohistochemical study of 55 cases challenging the existence of adenofibroma.
  • Mullerian adenosarcomas are rare mixed tumors of low malignant potential that occur mainly in the uterus and also in extrauterine locations.
  • In this clinicopathologic study of 55 adenosarcomas, the mean patient age was 50 years (range: 13 to 83 y).
  • Four had adenosarcomas with sarcomatous overgrowth; however, the other 2 patients had typical low-grade adenosarcomas of the uterine corpus and cervix, respectively, exhibiting only mild nuclear atypia of the stromal component and </=2 mitotic figures/10 high power fields.
  • The finding of such cases, which raises the controversy of whether or not adenofibroma exists as a tumor entity, prompted us to make a comparative immunohistochemical analysis of 23 typical adenosarcomas, 8 adenosarcomas with sarcomatous overgrowth, and 29 benign and malignant related lesions, including 7 clinically benign adenofibromas.
  • Adenosarcomas with sarcomatous overgrowth showed strong immunoreaction for Ki-67 and p53 and loss of CD10 and progesterone receptors immunostaining; in contrast, the immunoreaction for these tumor markers in typical adenosarcomas without sarcomatous overgrowth was similar to that of adenofibromas associated with favorable outcome and other benign lesions such as endometrial polyps and endometriosis.
  • These findings suggest that some of the tumors currently classified as adenofibromas, on the basis of their low mitotic count and lack of significant nuclear atypia, are, in fact, well-differentiated adenosarcomas.
  • [MeSH-major] Adenofibroma / pathology. Adenosarcoma / pathology. Genital Neoplasms, Female / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18941402.001).
  • [ISSN] 1532-0979
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


35. Stolnicu S, Balachandran K, Aleykutty MA, Loghin A, Preda O, Goez E, Nogales FF: Uterine adenosarcomas overgrown by sex-cord-like tumour: report of two cases. J Clin Pathol; 2009 Oct;62(10):942-4
MedlinePlus Health Information. consumer health - Uterine Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Uterine adenosarcomas overgrown by sex-cord-like tumour: report of two cases.
  • Müllerian adenosarcomas are tumours of low malignant potential with proliferation of benign glands and low grade endometrial stromal sarcoma (LGESS).
  • Two cases of uterine adenosarcomas massively overgrown by UTROSCT are reported, for the first time.
  • The patients, aged 71 and 64, one receiving tamoxifen, presented with intracavitary polypoid adenosarcomas; each was overgrown by an immunopathologically characteristic UTROSCT that constituted more than 75% of its volume.
  • Compared to the poor prognosis of adenosarcomas overgrown by high grade sarcomata, the cases reported here had a benign behaviour.
  • [MeSH-major] Adenosarcoma / pathology. Neoplasms, Multiple Primary / pathology. Sex Cord-Gonadal Stromal Tumors / pathology. Uterine Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19783725.001).
  • [ISSN] 1472-4146
  • [Journal-full-title] Journal of clinical pathology
  • [ISO-abbreviation] J. Clin. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


36. Mumba E, Ali H, Turton D, Cooper K, Grayson W: Human papillomaviruses do not play an aetiological role in Müllerian adenosarcomas of the uterine cervix. J Clin Pathol; 2008 Sep;61(9):1041-4
International Agency for Research on Cancer - Screening Group. diagnostics - Histopathology and cytopathology of the uterine cervix - digital atlas .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Human papillomaviruses do not play an aetiological role in Müllerian adenosarcomas of the uterine cervix.
  • AIM: To determine if human papillomaviruses (HPVs) play a role in the histogenesis of adenosarcomas of the uterine cervix.
  • METHODS: Nine archival cases of primary cervical adenosarcoma were studied.
  • CONCLUSION: HPVs do not appear to play an aetiological role in cervical adenosarcomas.
  • [MeSH-major] Adenosarcoma / virology. DNA, Viral / analysis. Papillomaviridae / genetics. Uterine Cervical Neoplasms / virology

  • MedlinePlus Health Information. consumer health - Cervical Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18552169.001).
  • [ISSN] 1472-4146
  • [Journal-full-title] Journal of clinical pathology
  • [ISO-abbreviation] J. Clin. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / DNA Primers; 0 / DNA, Viral
  •  go-up   go-down


37. Thiel DD, Erhard MJ: Uterine adenosarcoma in a boy with persistent müllerian duct syndrome: first reported case. J Pediatr Surg; 2005 Sep;40(9):e29-31
MedlinePlus Health Information. consumer health - Uterine Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Uterine adenosarcoma in a boy with persistent müllerian duct syndrome: first reported case.
  • We present imaging, surgical specimen, and surgical pathology of the first documented case of uterine adenosarcoma of a müllerian remnant in a 14-year-old boy with PMDS presenting with gross hematuria and increasing abdominal protuberance.
  • The child died of metastatic disease after surgical resection.
  • [MeSH-major] Adenosarcoma / pathology. Adenosarcoma / surgery. Disorders of Sex Development. Mullerian Ducts / abnormalities. Uterine Neoplasms / pathology. Uterine Neoplasms / surgery

  • Genetic Alliance. consumer health - Persistent Mullerian duct syndrome.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16150330.001).
  • [ISSN] 1531-5037
  • [Journal-full-title] Journal of pediatric surgery
  • [ISO-abbreviation] J. Pediatr. Surg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


38. Lee SJ, Bae JH, Kim DC, Park JS, Namkoong SE: Oral progesterone treatment in a young woman with müllerian adenosarcoma whose ovary was preserved: a case report. Int J Gynecol Cancer; 2010 Oct;20(7):1222-4
MedlinePlus Health Information. consumer health - Uterine Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Oral progesterone treatment in a young woman with müllerian adenosarcoma whose ovary was preserved: a case report.
  • Müllerian adenosarcoma is a rare biphasic tumor in young women.
  • A 35-year-old woman had a diagnosis of adenosarcoma on hysteroscopic resection, which was estrogen and progesterone receptor positive.
  • At 15 months after surgery, there has been no disease recurrence.
  • Oral medroxyprogesterone acetate therapy can be used effectively in young women with müllerian adenosarcoma whose ovaries are preserved.
  • [MeSH-major] Adenosarcoma / drug therapy. Antineoplastic Agents, Hormonal / administration & dosage. Medroxyprogesterone Acetate / administration & dosage. Mixed Tumor, Mullerian / drug therapy. Ovary / drug effects. Pregnancy Complications, Neoplastic / drug therapy. Uterine Neoplasms / drug therapy

  • MedlinePlus Health Information. consumer health - Tumors and Pregnancy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21495235.001).
  • [ISSN] 1525-1438
  • [Journal-full-title] International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
  • [ISO-abbreviation] Int. J. Gynecol. Cancer
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents, Hormonal; C2QI4IOI2G / Medroxyprogesterone Acetate
  •  go-up   go-down


39. Niculescu M, Simionescu C, Novac L, Mogoantă L, Mîndrilă I: Adenosarcoma of the uterine cervix: positive and differential diagnosis. Rom J Morphol Embryol; 2007;48(1):79-82
International Agency for Research on Cancer - Screening Group. diagnostics - A practical manual on visual screening for cervical neoplasia .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adenosarcoma of the uterine cervix: positive and differential diagnosis.
  • Adenosarcoma is considered as being a variety of mixed Müllerian tumor having a small grade of malignity.
  • [MeSH-major] Adenosarcoma / pathology. Leiomyosarcoma / pathology. Uterine Cervical Neoplasms / pathology
  • [MeSH-minor] Diagnosis, Differential. Female. Humans. Middle Aged. Mixed Tumor, Mullerian / diagnosis

  • MedlinePlus Health Information. consumer health - Cervical Cancer.
  • International Agency for Research on Cancer - Screening Group. diagnostics - Histopathology and cytopathology of the uterine cervix - digital atlas .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17502957.001).
  • [ISSN] 1220-0522
  • [Journal-full-title] Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie
  • [ISO-abbreviation] Rom J Morphol Embryol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Romania
  •  go-up   go-down


40. Yasuoka H, Tsujimoto M, Fujita S, Yamasaki T, Kashihara H, Nishio Y, Kodama R, Inagaki M, Oishi H, Sanke T, Nakamura Y: Coexistence of a clear cell adenocarcinoma and an adenosarcoma with a heterologous rhabdomyosarcoma in an endometriotic cyst of the ovary: a case study. Int J Gynecol Pathol; 2009 Jul;28(4):362-6
MedlinePlus Health Information. consumer health - Ovarian Cysts.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Coexistence of a clear cell adenocarcinoma and an adenosarcoma with a heterologous rhabdomyosarcoma in an endometriotic cyst of the ovary: a case study.
  • SUMMARY: A rare case of a clear cell adenocarcinoma and an adenosarcoma coexisting with a heterologous rhabdomyosarcoma in an endometriotic cyst of the ovary is reported.
  • Using X-chromosomal clonality assay, these clear cell adenocarcinoma and adenosarcoma components showed patterns of polyclonality.
  • To the authors' knowledge, this is the first reported case of a clear cell adenocarcinoma and an adenosarcoma coexisting with heterologous rhabdomyosarcoma in an endometriotic cyst of the ovary.
  • [MeSH-major] Adenocarcinoma, Clear Cell / pathology. Adenosarcoma / pathology. Neoplasms, Multiple Primary / pathology. Ovarian Cysts / pathology. Ovarian Neoplasms / pathology. Rhabdomyosarcoma / pathology

  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19483627.001).
  • [ISSN] 1538-7151
  • [Journal-full-title] International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
  • [ISO-abbreviation] Int. J. Gynecol. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Receptors, Androgen
  •  go-up   go-down


41. Soh E, Eleti A, Jimenez-Linan M, Arends MJ, Latimer J, Sala E: Magnetic resonance imaging findings of tamoxifen-associated uterine Müllerian adenosarcoma: a case report. Acta Radiol; 2008 Sep;49(7):848-51
Hazardous Substances Data Bank. TAMOXIFEN .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Magnetic resonance imaging findings of tamoxifen-associated uterine Müllerian adenosarcoma: a case report.
  • Müllerian adenosarcoma of the uterus is a rare biphasic tumor, which was first described in 1974.
  • [MeSH-major] Adenosarcoma / chemically induced. Adenosarcoma / diagnosis. Antineoplastic Agents, Hormonal / adverse effects. Magnetic Resonance Imaging / methods. Mullerian Ducts / pathology. Tamoxifen / adverse effects. Uterine Neoplasms / chemically induced. Uterine Neoplasms / diagnosis

  • MedlinePlus Health Information. consumer health - MRI Scans.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19143068.001).
  • [ISSN] 1600-0455
  • [Journal-full-title] Acta radiologica (Stockholm, Sweden : 1987)
  • [ISO-abbreviation] Acta Radiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Sweden
  • [Chemical-registry-number] 0 / Antineoplastic Agents, Hormonal; 094ZI81Y45 / Tamoxifen
  •  go-up   go-down


42. Huang GS, Arend RC, Sakaris A, Hebert TM, Goldberg GL: Extragenital adenosarcoma: a case report, review of the literature, and management discussion. Gynecol Oncol; 2009 Dec;115(3):472-5
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Extragenital adenosarcoma: a case report, review of the literature, and management discussion.
  • BACKGROUND: Müllerian adenosarcoma is a rare mixed epithelial-mesenchymal tumor.
  • CASE: We present a rare case of extragenital adenosarcoma with sarcomatous overgrowth and coexistent endometriosis.
  • She underwent a second surgery for management of a high-grade bowel obstruction, due to pathologically confirmed recurrent intraperitoneal adenosarcoma.
  • A complete clinical response was achieved with liposomal doxorubicin, and the patient remains disease-free eighteen months after completion of chemotherapy.
  • CONCLUSION: Liposomal doxorubicin appears to be an active agent for the treatment of adenosarcoma with sarcomatous overgrowth.
  • In addition, we conclude from our review of all reported cases of extragenital adenosarcoma that concurrent endometriosis may represent a favorable prognostic factor.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19712965.001).
  • [ISSN] 1095-6859
  • [Journal-full-title] Gynecologic oncology
  • [ISO-abbreviation] Gynecol. Oncol.
  • [Language] ENG
  • [Grant] United States / NICHD NIH HHS / HD / K12 HD000849; United States / NICHD NIH HHS / HD / 5K12HD00849; United States / NCI NIH HHS / CA / L30 CA124342; United States / NCI NIH HHS / CA / CA124342-02; United States / NCI NIH HHS / CA / L30 CA124342-02
  • [Publication-type] Case Reports; Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Other-IDs] NLM/ NIHMS141852; NLM/ PMC4451226
  •  go-up   go-down


43. Zámecník M, Sosna B, Chlumská A: Gastrointestinal stromal tumor (GIST) with glandular component. A report of an unusual tumor resembling adenosarcoma. Cesk Patol; 2005 Oct;41(4):150-6
MedlinePlus Health Information. consumer health - Stomach Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Gastrointestinal stromal tumor (GIST) with glandular component. A report of an unusual tumor resembling adenosarcoma.
  • Histologically, the lesion showed a biphasic adenosarcoma-like structure.
  • [MeSH-major] Adenosarcoma / pathology. Gastrointestinal Stromal Tumors / pathology. Stomach Neoplasms / pathology

  • Genetic Alliance. consumer health - Gastrointestinal Stromal Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16382991.001).
  • [ISSN] 1210-7875
  • [Journal-full-title] Československá patologie
  • [ISO-abbreviation] Cesk Patol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Czech Republic
  •  go-up   go-down


44. Kanngurn S, Somran J, Art-Ong C, Lamlertthon W, Porncharoenpong S: Primary peritoneal adenosarcoma with stromal overgrowth and fetal type cartilage: a case report and literature review. J Med Assoc Thai; 2005 Jun;88(6):849-54

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary peritoneal adenosarcoma with stromal overgrowth and fetal type cartilage: a case report and literature review.
  • Primary peritoneal adenosarcoma with sarcomatous overgrowth and fetal-type cartilage presented in a 48-year-old female patient is described.
  • The extrauterine adenosarcomas were reported in other sites, e.g. cervix, ovary, fallopian tube, bladder, and peritoneum.
  • This case was the ninth case of the primary peritoneal adenosarcoma in the English literature and the first report in Thailand.
  • [MeSH-major] Adenosarcoma / pathology. Cartilage / pathology. Peritoneal Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16083229.001).
  • [ISSN] 0125-2208
  • [Journal-full-title] Journal of the Medical Association of Thailand = Chotmaihet thangphaet
  • [ISO-abbreviation] J Med Assoc Thai
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Thailand
  • [Number-of-references] 22
  •  go-up   go-down


45. Abu J, Ireland D, Brown L: Adenosarcoma of an endometrial polyp in a 27-year-old nulligravida: a case report. J Reprod Med; 2007 Apr;52(4):326-8

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adenosarcoma of an endometrial polyp in a 27-year-old nulligravida: a case report.
  • BACKGROUND: Endometrial adenosarcoma is a rare tumor first described by Clement and Scully in 1974.
  • On examination, tissue protruding from the external cervical os is a common finding, with a smaller number of patients having an enlarged uterus or palpable pelvic mass.
  • CASE: Endometrial polyp adenosarcoma occurred in a 27-year-old, nulligravid woman who presented with intermenstrual and postcoital bleeding.
  • CONCLUSION: A clinical dilemma was encountered in the management of a young woman with endometrial polyp adenosarcoma because of the necessity to preserve her fertility.
  • [MeSH-major] Adenosarcoma / surgery. Endometrial Neoplasms / surgery. Fertility / physiology. Polyps / surgery
  • [MeSH-minor] Adult. Disease-Free Survival. Female. Humans. Magnetic Resonance Imaging. Time Factors

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17506376.001).
  • [ISSN] 0024-7758
  • [Journal-full-title] The Journal of reproductive medicine
  • [ISO-abbreviation] J Reprod Med
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


46. Chung YW, Bae HS, Han SI, Song JY, Kim IS, Kang JS: Endometrial mullerian adenosarcoma after toremifene treatment in breast cancer patients: a case report. J Gynecol Oncol; 2010 Dec 30;21(4):269-72

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Endometrial mullerian adenosarcoma after toremifene treatment in breast cancer patients: a case report.
  • We report a case of an adenosarcoma, which is a very rare type of uterine malignancy, after toremifene treatment for 5 years in a breast cancer patient.
  • After 1 year of toremifene use, the patient had a benign Mullerian adenofibroma.
  • After an additional 4 years of toremifene treatment, the endometrial polypoid lesion was transformed into a Mullerian adenosarcoma.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Rev Hosp Clin Fac Med Sao Paulo. 2000 Jan-Feb;55(1):17-20 [10881074.001]
  • [Cites] J Clin Oncol. 2000 Oct 15;18(20):3487-94 [11032589.001]
  • [Cites] Arch Gynecol Obstet. 2000 Sep;264(2):105-7 [11045336.001]
  • [Cites] Br J Cancer. 2001 Apr 6;84(7):897-902 [11286468.001]
  • [Cites] AJR Am J Roentgenol. 2003 Dec;181(6):1673-5 [14627594.001]
  • [Cites] Breast. 2006 Apr;15(2):142-57 [16289904.001]
  • [Cites] Int J Gynecol Cancer. 2006 Mar-Apr;16(2):861-5 [16681774.001]
  • [Cites] Eur J Cancer. 2009 Mar;45(4):561-71 [19062268.001]
  • [Cites] Breast Cancer Res Treat. 1993;25(1):57-63 [8518408.001]
  • [Cites] Ann Oncol. 2004 Dec;15(12):1749-59 [15550579.001]
  • (PMID = 21278890.001).
  • [ISSN] 2005-0399
  • [Journal-full-title] Journal of gynecologic oncology
  • [ISO-abbreviation] J Gynecol Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Korea (South)
  • [Other-IDs] NLM/ PMC3026307
  • [Keywords] NOTNLM ; Breast cancer / Mullerian adenofibroma / Mullerian adenosarcoma / Tamoxifen / Toremifene
  •  go-up   go-down


47. Farhat F, Fakhruddine N: A case of synchronous relapse of breast cancer and uterine müllerian adenosarcoma post tamoxifen in a premenopausal woman. Eur J Gynaecol Oncol; 2008;29(1):95-7
Hazardous Substances Data Bank. TAMOXIFEN .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A case of synchronous relapse of breast cancer and uterine müllerian adenosarcoma post tamoxifen in a premenopausal woman.
  • PURPOSE & METHODS: We report a case of a 42-year-old multigravida, premenopausal woman with breast carcinoma, who presented after four years of use of adjuvant tamoxifen with synchronous liver, bone, and lung metastasis of breast cancer with müllerian adenosarcoma.
  • She died 14 months after her relapse because of progressive disease (cerebral, bone, liver and lung metastases).
  • CONCLUSION: Our case is the only one reported in the literature with synchronous relapse of breast adenocarcinoma and a Müllerian adenosarcoma.
  • [MeSH-major] Adenosarcoma / pathology. Breast Neoplasms / drug therapy. Mixed Tumor, Mullerian / pathology. Neoplasm Recurrence, Local / complications. Tamoxifen / adverse effects. Uterine Neoplasms / pathology

  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18386476.001).
  • [ISSN] 0392-2936
  • [Journal-full-title] European journal of gynaecological oncology
  • [ISO-abbreviation] Eur. J. Gynaecol. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Italy
  • [Chemical-registry-number] 094ZI81Y45 / Tamoxifen
  • [Number-of-references] 12
  •  go-up   go-down


48. Coogan MP, Court JB, Gray VL, Hayes AJ, Lloyd SH, Millet CO, Pope SJ, Lloyd D: Probing intracellular oxygen by quenched phosphorescence lifetimes of nanoparticles containing polyacrylamide-embedded [Ru(dpp(SO3Na)2)3]Cl2. Photochem Photobiol Sci; 2010 Jan;9(1):103-9
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • However, electroporation was not required for particle uptake into a cultured human cell-line (mammary adenosarcoma MCF-7), although the intracellular distribution of the probe is more general to intracellular compartments when electroporation is employed.

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. OXYGEN .
  • Hazardous Substances Data Bank. POLYACRYLAMIDE .
  • Saccharomyces Genome Database. Saccharomyces Genome Database .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20062850.001).
  • [ISSN] 1474-9092
  • [Journal-full-title] Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology
  • [ISO-abbreviation] Photochem. Photobiol. Sci.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Acrylic Resins; 0 / Luminescent Agents; 0 / Organometallic Compounds; 0 / Phenanthrolines; 0 / ruthenium tris(4,7-diphenyphenanthrolyldisulfonate); 9003-05-8 / polyacrylamide; S88TT14065 / Oxygen
  •  go-up   go-down


49. Dillon K, Boyde A, Murphy JK, McCluggage WG: Ovarian serous cystadenofibroma with stromal sex cord elements: report of a unique case. Int J Gynecol Pathol; 2006 Oct;25(4):336-9
MedlinePlus Health Information. consumer health - Ovarian Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • True sex cord structures or sex cord-like elements have been described in ovarian adenosarcomas and pure stromal tumors, especially fibromas.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16990708.001).
  • [ISSN] 0277-1691
  • [Journal-full-title] International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
  • [ISO-abbreviation] Int. J. Gynecol. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / CA-125 Antigen; 0 / CALB2 protein, human; 0 / Calbindin 2; 0 / S100 Calcium Binding Protein G; 0 / inhibin-alpha subunit; 57285-09-3 / Inhibins
  •  go-up   go-down


50. Benito V, Lubrano A, Arencibia O, Andújar M, Alvarez E, Medina N, Falcón JM, Falcón O: Clinicopathologic analysis of uterine sarcomas from a single institution in the Canary Islands. Int J Gynaecol Obstet; 2009 Oct;107(1):44-9
MedlinePlus Health Information. consumer health - Uterine Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: The study included 89 patients: 48.4% with MMMT; 22.4% with leiomyosarcomas; 20.2% with endometrial stromal sarcomas; and 9% with adenosarcomas.
  • [MeSH-major] Mixed Tumor, Mullerian / pathology. Sarcoma / pathology. Uterine Neoplasms / pathology
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Disease-Free Survival. Female. Follow-Up Studies. Humans. Kaplan-Meier Estimate. Middle Aged. Multivariate Analysis. Neoplasm Staging. Prognosis. Retrospective Studies. Spain. Survival Rate. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19555952.001).
  • [ISSN] 1879-3479
  • [Journal-full-title] International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
  • [ISO-abbreviation] Int J Gynaecol Obstet
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


51. Roomi MW, Monterrey JC, Kalinovsky T, Rath M, Niedzwiecki A: Distinct patterns of matrix metalloproteinase-2 and -9 expression in normal human cell lines. Oncol Rep; 2009 Mar;21(3):821-6
Hazardous Substances Data Bank. 12-O-TETRADECANOYLPHORBOL-13-ACETATE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Epithelial, connective, and muscle tissues were selected since carcinomas, sarcomas, and adenosarcomas are derived from these tissue types, respectively.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19212645.001).
  • [ISSN] 1021-335X
  • [Journal-full-title] Oncology reports
  • [ISO-abbreviation] Oncol. Rep.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Greece
  • [Chemical-registry-number] EC 3.4.24.24 / Matrix Metalloproteinase 2; EC 3.4.24.35 / Matrix Metalloproteinase 9; NI40JAQ945 / Tetradecanoylphorbol Acetate
  •  go-up   go-down


52. Schmidt D: [Changes in the endometrium after tamoxifen therapy]. Pathologe; 2006 Feb;27(1):27-32
Hazardous Substances Data Bank. TAMOXIFEN .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • These are adenosarcomas, carcinosarcomas and endometrial stromal sarcomas.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] AJR Am J Roentgenol. 1997 Mar;168(3):657-61 [9057510.001]
  • [Cites] Gynecol Oncol. 2000 Aug;78(2):181-6 [10926800.001]
  • [Cites] Int J Gynecol Cancer. 2000 Jul;10(4):280-284 [11240687.001]
  • [Cites] J Cell Biochem Suppl. 1995;23:179-83 [8747394.001]
  • [Cites] Gynecol Oncol. 2004 Aug;94(2):256-66 [15297160.001]
  • [Cites] Schweiz Med Wochenschr. 1999 Dec 11;129(49):1926-30 [10635085.001]
  • [Cites] Cancer. 2003 Nov 1;98(9):1890-7 [14584071.001]
  • [Cites] Pathologe. 1987 May;8(3):138-40 [3303008.001]
  • [Cites] Arch Gynecol Obstet. 2000 Apr;263(4):170-7 [10834325.001]
  • [Cites] J Natl Cancer Inst. 1994 Apr 6;86(7):527-37 [8133536.001]
  • [Cites] Int J Gynecol Pathol. 1995 Jan;14(1):7-15 [7883429.001]
  • [Cites] Cancer Treat Rep. 1985 Feb;69(2):237-8 [3971394.001]
  • [Cites] Obstet Gynecol. 1998 Jan;91(1):40-4 [9464718.001]
  • [Cites] Eur J Obstet Gynecol Reprod Biol. 2002 Feb 10;101(1):58-63 [11803101.001]
  • [Cites] Gynecol Oncol. 1998 Aug;70(2):188-91 [9740688.001]
  • [Cites] Lancet. 2000 Sep 9;356(9233):881-7 [11036892.001]
  • [Cites] South Med J. 2003 May;96(5):469-76 [12911186.001]
  • [Cites] J Clin Oncol. 2000 Oct 15;18(20):3459-63 [11032585.001]
  • [Cites] Hum Pathol. 2003 Sep;34(9):939-43 [14562291.001]
  • (PMID = 16362260.001).
  • [ISSN] 0172-8113
  • [Journal-full-title] Der Pathologe
  • [ISO-abbreviation] Pathologe
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Estrogen Antagonists; 094ZI81Y45 / Tamoxifen
  •  go-up   go-down


53. Johnson SR, Ettinger B, Macer JL, Ensrud KE, Quan J, Grady D: Uterine and vaginal effects of unopposed ultralow-dose transdermal estradiol. Obstet Gynecol; 2005 Apr;105(4):779-87
Hazardous Substances Data Bank. ESTRADIOL .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In the estradiol group, focal atypical endometrial hyperplasia developed in 1 woman, and adenosarcoma of the uterus developed in 1 woman.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15802405.001).
  • [ISSN] 0029-7844
  • [Journal-full-title] Obstetrics and gynecology
  • [ISO-abbreviation] Obstet Gynecol
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 4TI98Z838E / Estradiol
  •  go-up   go-down


54. Köhler G: [Uterine sarcoma treatment]. Pathologe; 2009 Jul;30(4):304-12
MedlinePlus Health Information. consumer health - Uterine Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • There are many common features between uterine sarcomas - leiomyosarcoma, endometrial stromal sarcoma, undifferentiated endometrial sarcoma and adenosarcoma -with regards to course, therapy and follow-up, such as post-menopausal bleeding or additional premenopausal bleeding, as well as rapid growth.
  • In the case of disease spread in uterine sarcomas and malignant mixed tumors, good supportive therapy is a possible therapy option instead of chemo- or radiotherapy.

  • Genetic Alliance. consumer health - Uterine sarcoma.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Gynecol Oncol. 1994 Jan;52(1):74-9 [8307505.001]
  • [Cites] Gynecol Oncol. 2003 Jun;89(3):460-9 [12798712.001]
  • [Cites] Cancer. 2008 Feb 15;112(4):820-30 [18189292.001]
  • [Cites] Gynecol Oncol. 2001 Oct;83(1):89-94 [11585418.001]
  • [Cites] Gynecol Oncol. 2004 Feb;92(2):644-7 [14766260.001]
  • [Cites] Gynecol Oncol. 1993 Jul;50(1):105-9 [8349151.001]
  • [Cites] J Clin Oncol. 1985 Sep;3(9):1240-5 [3897471.001]
  • [Cites] Int J Gynecol Cancer. 2008 Sep-Oct;18(5):1084-9 [18179547.001]
  • [Cites] Curr Opin Oncol. 2007 Jul;19(4):347-52 [17545798.001]
  • [Cites] Gynecol Oncol. 2009 Mar;112(3):563-7 [19135708.001]
  • [Cites] Oncol Rep. 1998 Jul-Aug;5(4):939-44 [9625851.001]
  • [Cites] Crit Rev Oncol Hematol. 2008 Feb;65(2):129-42 [17706430.001]
  • [Cites] Gynecol Oncol. 1996 Aug;62(2):226-9 [8751554.001]
  • [Cites] Ann Surg. 1999 May;229(5):602-10; discussion 610-2 [10235518.001]
  • [Cites] Ann Surg. 2000 Apr;231(4):500-5 [10749609.001]
  • [Cites] Gynecol Oncol. 2008 Jul;110(1):43-8 [18445505.001]
  • [Cites] Int J Gynecol Cancer. 2007 Sep-Oct;17(5):957-63 [17359294.001]
  • [Cites] Gynecol Oncol. 2008 Oct;111(1):74-81 [18657852.001]
  • [Cites] Cancer. 1993 Feb 15;71(4 Suppl):1702-9 [8381710.001]
  • [Cites] Cancer. 1983 Aug 15;52(4):626-32 [6344983.001]
  • [Cites] Int J Gynecol Pathol. 1992;11(2):75-88 [1316323.001]
  • [Cites] Gynecol Oncol. 1990 Jan;36(1):113-8 [2295442.001]
  • [Cites] Eur J Obstet Gynecol Reprod Biol. 2009 May;144(1):80-4 [19269732.001]
  • [Cites] Eur J Gynaecol Oncol. 2006;27(2):150-2 [16620058.001]
  • [Cites] Gynecol Obstet Fertil. 2003 Feb;31(2):147-50 [12718990.001]
  • [Cites] Gynecol Oncol. 2007 Jul;106(1):82-8 [17434579.001]
  • [Cites] Gynecol Oncol. 2003 Jul;90(1):170-6 [12821359.001]
  • [Cites] J Clin Oncol. 2007 Jul 20;25(21):3144-50 [17634494.001]
  • [Cites] Am J Obstet Gynecol. 1992 Feb;166(2):556-9 [1536229.001]
  • [Cites] Obstet Gynecol. 1996 May;87(5 Pt 1):747-50 [8677079.001]
  • [Cites] Curr Opin Oncol. 2007 Sep;19(5):492-6 [17762577.001]
  • [Cites] Br J Cancer. 1995 Aug;72(2):469-75 [7640234.001]
  • [Cites] Gynecol Oncol. 2008 Jun;109(3):329-34 [18534250.001]
  • [Cites] Br J Cancer. 2007 Nov 5;97(9):1194-9 [17895898.001]
  • [Cites] Obstet Gynecol. 2008 Jul;112(1):64-70 [18591309.001]
  • [Cites] Eur J Obstet Gynecol Reprod Biol. 1998 Feb;76(2):237-40 [9481582.001]
  • [Cites] Mod Pathol. 2004 Jan;17(1):104-8 [14631363.001]
  • [Cites] Gynecol Oncol. 1996 Jul;62(1):25-32 [8690287.001]
  • [Cites] Gynecol Oncol. 2005 Oct;99(1):36-42 [15992918.001]
  • [Cites] Int J Gynecol Cancer. 2005 Jan-Feb;15(1):132-9 [15670308.001]
  • [Cites] Hum Pathol. 1990 Apr;21(4):363-81 [2156771.001]
  • [Cites] Eur J Cancer. 2008 Apr;44(6):808-18 [18378136.001]
  • [Cites] Eur J Gynaecol Oncol. 2008;29(2):129-34 [18459545.001]
  • [Cites] Gynecol Oncol. 2006 Jun;101(3):464-9 [16368128.001]
  • [Cites] Int J Gynecol Cancer. 2006 May-Jun;16(3):1358-63 [16803530.001]
  • [Cites] Gynecol Oncol. 1996 Aug;62(2):254-9 [8751558.001]
  • [Cites] Clin Oncol (R Coll Radiol). 2008 Aug;20(6):470-8 [18572394.001]
  • [Cites] Oncology. 2006;71(5-6):333-40 [17690557.001]
  • [Cites] Gynecol Oncol. 2004 Feb;92(2):648-52 [14766261.001]
  • [Cites] Am J Surg Pathol. 2008 Jul;32(7):1013-21 [18469708.001]
  • [Cites] Gynecol Oncol. 2007 Apr;105(1):256-60 [17292949.001]
  • [Cites] Obstet Gynecol. 2008 Nov;112(5):1102-8 [18978112.001]
  • [Cites] Obstet Gynecol. 2005 Dec;106(6):1304-8 [16319256.001]
  • [Cites] Br J Cancer. 2008 Oct 21;99(8):1210-5 [18813312.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2003 Dec 1;57(5):1366-73 [14630275.001]
  • [Cites] Ann Surg Oncol. 2005 Jun;12(6):459-66 [15886903.001]
  • [Cites] Eur J Cancer. 1997 May;33(6):907-11 [9291814.001]
  • [Cites] Gynecol Oncol. 2005 Oct;99(1):243-5 [16054205.001]
  • [Cites] Br J Cancer. 2000 Mar;82(5):1030-4 [10737385.001]
  • [Cites] Int J Gynecol Cancer. 2007 May-Jun;17(3):724-8 [17300682.001]
  • [Cites] Am J Surg Pathol. 2008 Aug;32(8):1228-38 [18580489.001]
  • [Cites] Gynecol Oncol. 2004 Apr;93(1):204-8 [15047237.001]
  • [Cites] Am J Obstet Gynecol. 2008 Nov;199(5):536.e1-8 [18511017.001]
  • [Cites] Gynecol Oncol. 2005 Feb;96(2):402-6 [15661228.001]
  • [Cites] J Clin Oncol. 2009 Apr 20;27(12):2066-72 [19255317.001]
  • [Cites] Ann Surg. 2001 Oct;234(4):540-7; discussion 547-8 [11573047.001]
  • [Cites] Gynecol Oncol. 2007 Dec;107(3):518-25 [17910981.001]
  • [Cites] Gynecol Oncol. 2007 Jan;104(1):260-3 [17083970.001]
  • [Cites] Gynecol Oncol. 1992 May;45(2):202-5 [1592288.001]
  • [Cites] Gynecol Oncol. 2007 Jun;105(3):630-4 [17320937.001]
  • [Cites] Int J Gynecol Pathol. 1999 Jan;18(1):20-8 [9891238.001]
  • [Cites] J Obstet Gynaecol Can. 2008 Jun;30(6):500-4 [18611301.001]
  • [Cites] Histopathology. 2009 Feb;54(3):355-64 [19236512.001]
  • [Cites] Int J Gynecol Cancer. 2009 Feb;19(2):253-6 [19396004.001]
  • [Cites] Int J Gynecol Cancer. 2009 Feb;19(2):257-60 [19396005.001]
  • [Cites] Int J Gynecol Cancer. 2004 Nov-Dec;14(6):1118-21 [15571618.001]
  • [Cites] Gynecol Oncol. 2002 Dec;87(3):287-94 [12468327.001]
  • [Cites] Gynecol Oncol. 2003 Oct;91(1):209-12 [14529683.001]
  • [Cites] Cancer. 1985 Apr 15;55(8):1648-53 [3884128.001]
  • [Cites] Gynecol Oncol. 2008 Feb;108(2):306-11 [18061249.001]
  • [Cites] Am J Surg Pathol. 2009 Feb;33(2):278-88 [18941402.001]
  • [Cites] J Clin Oncol. 2002 Jun 15;20(12):2824-31 [12065559.001]
  • (PMID = 19517111.001).
  • [ISSN] 1432-1963
  • [Journal-full-title] Der Pathologe
  • [ISO-abbreviation] Pathologe
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


55. Erdogan G, Bassorgun CI, Pestereli HE, Simsek T, Karaveli S: C-kit protein expression in uterine and ovarian mesenchymal tumours. APMIS; 2007 Mar;115(3):204-9
MedlinePlus Health Information. consumer health - Uterine Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The morphologic similarity of uterine mesenchymal tumours and GIST, and the presence of KIT protein in normal uterine tissue, suggests that uterine sarcomas may have the same c-kit overexpression.
  • Immunohistochemical staining using a polyclonal anti-c-kit antibody was performed on tissue blocks from 12 carsinosarcomas, 14 leiomyosarcomas, 8 endometrial stromal sarcomas, 2 adenosarcomas, 1 atypical leiomyoma, 1 leiomyoma with limited experience, and 10 leiomyomas.
  • C-kit was positive in 10 of 12 (83%) carcinosarcomas, 10 of 14 (71%) leiomyosarcomas, 6 of 8 75(%) endometrial stromal sarcomas, 1 of 2 (50%) adenosarcomas, 1 leiomyoma with limited experience, and 1 of 10 (10%) leiomyomas.

  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17367465.001).
  • [ISSN] 0903-4641
  • [Journal-full-title] APMIS : acta pathologica, microbiologica, et immunologica Scandinavica
  • [ISO-abbreviation] APMIS
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Denmark
  • [Chemical-registry-number] EC 2.7.10.1 / Proto-Oncogene Proteins c-kit
  •  go-up   go-down


56. Rovirosa A, Ascaso C, Ordi J, Arenas M, Valduvieco I, Lejarcegui JA, Pahisa J, Torne A, Biete A: How to deal with prognostic factors and radiotherapy results in uterine neoplasms with a sarcomatous component? Clin Transl Oncol; 2009 Oct;11(10):681-7
MedlinePlus Health Information. consumer health - Uterine Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The aim of this study was to evaluate the prognostic factors by stages and to assess the impact of prognostic factors and the effect of radiotherapy on the outcome of the disease.
  • The impact of pathologic prognostic factors and radiotherapy on specific overall survival (OS), disease-free survival (DFS), local relapse-free survival (LRFS) and distant metastasis-free survival (DMFS) were analysed by Log Rank test and Cox proportional risk models.
  • For pathological type the frequency by advanced vs. early stages was 54% vs. 52% for carcinosarcomas, 33.5% vs. 17.5% for leiomyosarcoma, and 30.5% and 12.5% for adenosarcoma and endometrial stromal sarcoma, respectively.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Oncol. 1985 Sep;3(9):1240-5 [3897471.001]
  • [Cites] Crit Rev Oncol Hematol. 2008 Feb;65(2):129-42 [17706430.001]
  • [Cites] Gynecol Oncol. 1997 Oct;67(1):70-5 [9345359.001]
  • [Cites] Cancer. 1993 Feb 15;71(4 Suppl):1702-9 [8381710.001]
  • [Cites] Gynecol Oncol. 2004 Jul;94(1):191-6 [15262141.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2002 Apr 1;52(5):1320-9 [11955745.001]
  • [Cites] Eur J Cancer. 1991;27(9):1095-9 [1835616.001]
  • [Cites] Eur J Surg Oncol. 2007 Feb;33(1):91-5 [17174517.001]
  • [Cites] AJR Am J Roentgenol. 1976 Jan;126(1):139-47 [175673.001]
  • [Cites] Gynecol Oncol. 1996 Jul;62(1):25-32 [8690287.001]
  • [Cites] Cancer. 2000 Jun 15;88(12):2782-6 [10870061.001]
  • [Cites] Gynecol Oncol. 1999 Aug;74(2):196-201 [10419731.001]
  • [Cites] Eur J Cancer. 2008 Apr;44(6):808-18 [18378136.001]
  • [Cites] Histopathology. 2004 May;44(5):472-9 [15139995.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2003 Dec 1;57(5):1366-73 [14630275.001]
  • [Cites] Gynecol Oncol. 1989 Sep;34(3):372-8 [2548936.001]
  • [Cites] Cancer. 2000 Mar 15;88(6):1425-31 [10717626.001]
  • [Cites] Gynecol Oncol. 1997 Apr;65(1):158-63 [9103406.001]
  • [Cites] Gynecol Oncol. 2004 Apr;93(1):204-8 [15047237.001]
  • [Cites] Med Clin (Barc). 1998 Jul 11;111(5):172-6 [9732833.001]
  • [Cites] Br J Radiol. 1993 Nov;66(791):1009-15 [8281375.001]
  • [Cites] Oncology. 1988;45(6):428-33 [3186152.001]
  • [Cites] Gynecol Oncol. 2005 May;97(2):624-37 [15863170.001]
  • [Cites] Br J Obstet Gynaecol. 1992 Jul;99(7):590-4 [1326319.001]
  • [Cites] Gynecol Oncol. 1999 Feb;72(2):232-7 [10021306.001]
  • (PMID = 19828411.001).
  • [ISSN] 1699-3055
  • [Journal-full-title] Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
  • [ISO-abbreviation] Clin Transl Oncol
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Italy
  •  go-up   go-down


57. Euscher ED, Deavers MT, Lopez-Terrada D, Lazar AJ, Silva EG, Malpica A: Uterine tumors with neuroectodermal differentiation: a series of 17 cases and review of the literature. Am J Surg Pathol; 2008 Feb;32(2):219-28
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Clinical presentations included vaginal bleeding (9), back pain (1), presumed fibroids (2), pelvic mass (1), incidental finding at hysterectomy (1), and unknown (3).
  • In 7 tumors, the neuroectodermal component was admixed with an additional component including unclassified sarcoma (2 cases), rhabdomyosarcoma, endometrioid carcinoma, adenosarcoma and malignant mixed Mullerian tumor (2 cases).
  • Follow-up, available for 13 patients, ranged from 2 to 41 months with 7 patients dead of disease 2 to 26 months after diagnosis.
  • Six patients are alive with no evidence of disease after follow-up ranging from 6 to 41 months.

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18223324.001).
  • [ISSN] 0147-5185
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Calmodulin-Binding Proteins; 0 / EWSR1 protein, human; 0 / RNA-Binding Proteins
  •  go-up   go-down


58. McCluggage WG, Ganesan R, Herrington CS: Endometrial stromal sarcomas with extensive endometrioid glandular differentiation: report of a series with emphasis on the potential for misdiagnosis and discussion of the differential diagnosis. Histopathology; 2009 Feb;54(3):365-73

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Apart from endometriosis, other diagnostic considerations, depending on the tumour location and exact morphology, included adenomyosis, adenosarcoma and carcinosarcoma.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19236513.001).
  • [ISSN] 1365-2559
  • [Journal-full-title] Histopathology
  • [ISO-abbreviation] Histopathology
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


59. Chen XD, Shi HY, Zhang XF: [Clinicopathologic analysis of 102 cases of mixed epithelial and mesenchymal tumors of the uterus]. Zhonghua Fu Chan Ke Za Zhi; 2007 Apr;42(4):219-21
MedlinePlus Health Information. consumer health - Uterine Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: A retrospective study of 102 cases of MMT of the uterus (74 adenofibromas including 9 recurrent cases, 3 atypical polypoid adenomyomas, 2 carcinofibromas, 10 adenosarcomas and 13 carcinosarcomas) was undertaken.
  • Nine cases of adenofibroma without unique features for the diagnosis of adenosarcoma recurred at postoperative intervals of 3 to 96 months.
  • [MeSH-major] Mixed Tumor, Mullerian / pathology. Uterine Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17631758.001).
  • [ISSN] 0529-567X
  • [Journal-full-title] Zhonghua fu chan ke za zhi
  • [ISO-abbreviation] Zhonghua Fu Chan Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


60. Bettaieb I, Mekni A, Bellil K, Haouet S, Bellil S, Kchir N, Chelly H, Zitouna M: Endometrial adenofibroma: a rare entity. Arch Gynecol Obstet; 2007 Mar;275(3):191-3

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Endometrial adenofibroma is an uncommon mullerian mixed tumor composed of benign epithelial and mesenchymal components.
  • This tumor must be distinguished from other malignant lesions of the uterus, particularly adenosarcoma.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16858575.001).
  • [ISSN] 0932-0067
  • [Journal-full-title] Archives of gynecology and obstetrics
  • [ISO-abbreviation] Arch. Gynecol. Obstet.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


61. Schildhaus HU, Mikuz G, Fisang C, Steiner S, Büttner R, Wardelmann E: [Malignant mixed Müllerian tumor of the urinary bladder]. Pathologe; 2008 Sep;29(5):375-7
MedlinePlus Health Information. consumer health - Endometriosis.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • True mixed epithelial-mesenchymal tumors of the urinary bladder are exceedingly rare, and only two vesical adenosarcomas have been reported to date.
  • [MeSH-major] Endometriosis / pathology. Mixed Tumor, Mullerian / pathology. Urinary Bladder Neoplasms / pathology

  • Genetic Alliance. consumer health - Malignant mixed Mullerian tumor.
  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Pathol. 2002 May;55(5):391-2 [11986349.001]
  • [Cites] Fertil Steril. 2002 Oct;78(4):872-5 [12372471.001]
  • [Cites] Virchows Arch. 2004 Jun;444(6):587-9 [15221475.001]
  • [Cites] J Urol. 1990 Apr;143(4):813-5 [2156090.001]
  • (PMID = 18592241.001).
  • [ISSN] 1432-1963
  • [Journal-full-title] Der Pathologe
  • [ISO-abbreviation] Pathologe
  • [Language] ger
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


62. D'Angelo E, Prat J: Uterine sarcomas: a review. Gynecol Oncol; 2010 Jan;116(1):131-9
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Adenosarcomas have a favorable prognosis except for tumors showing myometrial invasion or sarcomatous overgrowth.
  • Adenofibromas may represent well-differentiated adenosarcomas.
  • [MeSH-minor] Adenosarcoma / metabolism. Adenosarcoma / pathology. Carcinosarcoma / metabolism. Carcinosarcoma / pathology. Female. Humans. Immunohistochemistry. Leiomyosarcoma / metabolism. Leiomyosarcoma / pathology. Neoplasm Staging. Sarcoma, Endometrial Stromal / metabolism. Sarcoma, Endometrial Stromal / pathology

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19853898.001).
  • [ISSN] 1095-6859
  • [Journal-full-title] Gynecologic oncology
  • [ISO-abbreviation] Gynecol. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] United States
  • [Number-of-references] 74
  •  go-up   go-down


63. Kildal W, Pradhan M, Abeler VM, Kristensen GB, Danielsen HE: Beta-catenin expression in uterine sarcomas and its relation to clinicopathological parameters. Eur J Cancer; 2009 Sep;45(13):2412-7
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Aberrations in the Wnt/beta-catenin signalling pathway are suggested as mediators of chromosomal instability and carcinogenesis. beta-catenin acts both as a component of the membranous adhesion system, and as a transcription activator in the nucleus. beta-Catenin immunoreactivity was evaluated in 353 uterine sarcomas (US) including 231 leiomyosarcomas (LMS), 82 endometrial stromal sarcomas (ESS), 22 adenosarcomas (AS) and 18 undifferentiated uterine sarcomas (UUS).

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19622417.001).
  • [ISSN] 1879-0852
  • [Journal-full-title] European journal of cancer (Oxford, England : 1990)
  • [ISO-abbreviation] Eur. J. Cancer
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Wnt Proteins; 0 / beta Catenin
  •  go-up   go-down


64. Abeler VM, Røyne O, Thoresen S, Danielsen HE, Nesland JM, Kristensen GB: Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients. Histopathology; 2009 Feb;54(3):355-64
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Stage of disease was the most important prognostic factor for all tumour types.
  • In adenosarcomas, tumour cell necrosis was the only significant prognostic factor.

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19236512.001).
  • [ISSN] 1365-2559
  • [Journal-full-title] Histopathology
  • [ISO-abbreviation] Histopathology
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


65. Tesfaye A, Di Cello F, Hillion J, Ronnett BM, Elbahloul O, Ashfaq R, Dhara S, Prochownik E, Tworkoski K, Reeves R, Roden R, Ellenson LH, Huso DL, Resar LM: The high-mobility group A1 gene up-regulates cyclooxygenase 2 expression in uterine tumorigenesis. Cancer Res; 2007 May 1;67(9):3998-4004
Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Histopathologically, the tumors resemble human uterine adenosarcoma and are transplantable.
  • To determine whether these findings are relevant to human disease, we evaluated primary human uterine neoplasms and found that HMGA1a mRNA and protein levels are increased in most high-grade neoplasms but not in normal uterine tissue, benign tumors, or most low-grade neoplasms.
  • [MeSH-major] Adenosarcoma / genetics. Cyclooxygenase 2 / biosynthesis. HMGA1a Protein / genetics. Uterine Neoplasms / genetics

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17483309.001).
  • [ISSN] 0008-5472
  • [Journal-full-title] Cancer research
  • [ISO-abbreviation] Cancer Res.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / R01 CA092339; United States / NCI NIH HHS / CA / T32 CA60441
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 124544-67-8 / HMGA1a Protein; EC 1.14.99.1 / Cyclooxygenase 2
  •  go-up   go-down


66. Vrzic-Petronijevic S, Likic-Ladjevic I, Petronijevic M, Argirovic R, Ladjevic N: Diagnosis and surgical therapy of uterine sarcoma. Acta Chir Iugosl; 2006;53(3):67-72
MedlinePlus Health Information. consumer health - Uterine Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Cases were distributed into groups based on definitive diagnosis of uterine sarcoma: group of leiomyosarcomas (LMS), carcinosarcoma (CS), endometrial stromal sarcomas (ESS), adenosarcomas (AS) and other rare uterine sarcomas.
  • Postoperative pathohistologic analysis showed that low grade (LG) leiomyosarcoma were present in 19 (35.9%) cases, high grade (HG) leiomyosarcoma in 1 (1.9%) case, carcinosarcoma in 14 (26.4%) cases, low grade (LG) endometrial stromal sarcoma in 5 (9.4%) cases, high grade (HG) endometrial stromal sarcoma in 9 (17.0%) cases, adenosarcoma in 2 (3.8%) cases, and 2 cases of rare uterine sarcomas: 1 (1.9%) MALT HG lymphoma and 1(1.9%) malignant hemangiopericytoma.

  • Genetic Alliance. consumer health - Uterine sarcoma.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17338203.001).
  • [ISSN] 0354-950X
  • [Journal-full-title] Acta chirurgica Iugoslavica
  • [ISO-abbreviation] Acta Chir Iugosl
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Serbia and Montenegro
  •  go-up   go-down


67. Bansal S, Lewin SN, Burke WM, Deutsch I, Sun X, Herzog TJ, Wright JD: Sarcoma of the cervix: natural history and outcomes. Gynecol Oncol; 2010 Aug 1;118(2):134-8
International Agency for Research on Cancer - Screening Group. diagnostics - Histopathology and cytopathology of the uterine cervix - digital atlas .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Among women with cervical sarcomas, carcinosarcoma was the most common and accounted for 40% (128) of the cases while adenosarcomas and leiomyosarcomas each accounted for 21% (67).
  • Compared to women with squamous cell and adenocarcinomas, patients with cervical sarcomas tended to be younger, diagnosed in the later years of the study, have larger tumors, and have more advanced stage disease (p<0.05 for all).

  • MedlinePlus Health Information. consumer health - Cervical Cancer.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2010 Elsevier Inc. All rights reserved.
  • (PMID = 20541244.001).
  • [ISSN] 1095-6859
  • [Journal-full-title] Gynecologic oncology
  • [ISO-abbreviation] Gynecol. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


68. Abu-Rustum NR, Chi DS, Leitao M, Oke EA, Hensley ML, Alektiar KM, Barakat RR: What is the incidence of isolated paraaortic nodal recurrence in grade 1 endometrial carcinoma? Gynecol Oncol; 2008 Oct;111(1):46-8
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Patients with any papillary serous or clear cell carcinoma, leiomyosarcoma, endometrial stromal sarcoma, squamous carcinoma, or adenosarcoma were excluded.

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18657853.001).
  • [ISSN] 1095-6859
  • [Journal-full-title] Gynecologic oncology
  • [ISO-abbreviation] Gynecol. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


69. Leung F, Terzibachian JJ, Aouar Z, Govyadovskiy A, Lassabe C: [Uterine sarcomas: clinical and histopathological aspects. Report on 15 cases]. Gynecol Obstet Fertil; 2008 Jun;36(6):628-35
MedlinePlus Health Information. consumer health - Uterine Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Our study included six histological types: carcinosarcoma (n=5), leiomyosarcoma (n=3), rhabdomyosarcoma (n=2), adenosarcoma (n=2), stromal sarcoma (n=2), and undifferentiated sarcoma (n=1).

  • MedlinePlus Health Information. consumer health - Hysterectomy.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18538624.001).
  • [ISSN] 1297-9589
  • [Journal-full-title] Gynécologie, obstétrique & fertilité
  • [ISO-abbreviation] Gynecol Obstet Fertil
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


70. Naik R, Cross P, Lopes A, Godfrey K, Hatem MH: "True" versus "apparent" stage I epithelial ovarian cancer: value of frozen section analysis. Int J Gynecol Cancer; 2006 Jan-Feb;16 Suppl 1:41-6
MedlinePlus Health Information. consumer health - Ovarian Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Four of seventy-four cases reported as benign on frozen section analysis were underdiagnosed; two were later diagnosed on paraffin section as borderline tumors and a further two as malignant (one low-grade adenosarcoma and one primary peritoneal cancer).
  • Additional benefits included the confirmation of malignancy where extraovarian lesions were suggestive but not indicative of malignant disease, and the intraoperative identification of metastatic disease of nonovarian origin.

  • Genetic Alliance. consumer health - Ovarian cancer.
  • Genetic Alliance. consumer health - Ovarian epithelial cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16515566.001).
  • [ISSN] 1048-891X
  • [Journal-full-title] International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
  • [ISO-abbreviation] Int. J. Gynecol. Cancer
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


71. Horn LC, Dallacker M, Bilek K: [Carcinosarcomas (malignant mixed Mullerian tumors) of the uterus. Morphology, pathogenetic aspects and prognostic factors]. Pathologe; 2009 Jul;30(4):292-301
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Carcinosarcomas (malignant mixed Mullerian tumors) of the uterus. Morphology, pathogenetic aspects and prognostic factors].
  • Malignant mixed Mullerian tumors (MMMT; carcinosarcomas) are rare epithelial-mesenchymal tumors.
  • Clinical, morphologic and molecular data suggest that MMMTs are really metaplastic carcinomas in which the mesenchymal part retains epithelial features.
  • The main differential diagnoses include uterine sarcomas, adenosarcoma and benign metaplastic change within the endometrium.

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Lancet Oncol. 2005 Dec;6(12):961-71 [16321764.001]
  • [Cites] Gynecol Oncol. 1997 Dec;67(3):316-21 [9441781.001]
  • [Cites] Int J Gynecol Pathol. 1990;9(1):1-19 [2152890.001]
  • [Cites] Gynecol Oncol. 2005 Aug;98(2):274-80 [15972232.001]
  • [Cites] Cancer. 2000 Jun 15;88(12):2782-6 [10870061.001]
  • [Cites] Gynecol Oncol. 2006 Nov;103(2):684-7 [16797683.001]
  • [Cites] Anticancer Res. 2001 Jul-Aug;21(4B):3069-74 [11712812.001]
  • [Cites] J Clin Pathol. 2002 May;55(5):321-5 [11986333.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):786-96 [14967435.001]
  • [Cites] Int J Gynecol Pathol. 2003 Jan;22(1):75-82 [12496702.001]
  • (PMID = 19495763.001).
  • [ISSN] 1432-1963
  • [Journal-full-title] Der Pathologe
  • [ISO-abbreviation] Pathologe
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


72. Hassini A, Khemiri B, Sfar E, Chelly D, Chennoufi MB, Chelly H: [Uterine sarcomas: clinical and therapeutic aspects (10 cases)]. J Gynecol Obstet Biol Reprod (Paris); 2006 Jun;35(4):348-55
MedlinePlus Health Information. consumer health - Uterine Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: There were 5 cases of leiomyosarcoma, 2 cases of carcinosarcoma, 2 cases of endometrial stromal sarcoma and 1 adenosarcoma.

  • MedlinePlus Health Information. consumer health - Hysterectomy.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16940904.001).
  • [ISSN] 0368-2315
  • [Journal-full-title] Journal de gynécologie, obstétrique et biologie de la reproduction
  • [ISO-abbreviation] J Gynecol Obstet Biol Reprod (Paris)
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] France
  • [Number-of-references] 40
  •  go-up   go-down


73. Arenas M, Rovirosa A, Hernández V, Ordi J, Jorcano S, Mellado B, Biete A: Uterine sarcomas in breast cancer patients treated with tamoxifen. Int J Gynecol Cancer; 2006 Mar-Apr;16(2):861-5
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Uterine sarcoma appeared 5, 5, and 7 years, respectively, after the start of TMX treatment, and all of them had stage I (FIGO) disease.
  • Two patients had a carcinosarcoma and one patient had an adenosarcoma.
  • After treatment, the disease progressed in two patients and the third patient is alive having a follow-up of 42 months.
  • [MeSH-major] Adenosarcoma / chemically induced. Antineoplastic Agents, Hormonal / adverse effects. Breast Neoplasms / drug therapy. Carcinosarcoma / chemically induced. Neoplasms, Second Primary / chemically induced. Tamoxifen / adverse effects. Uterine Neoplasms / chemically induced

  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • Hazardous Substances Data Bank. TAMOXIFEN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16681774.001).
  • [ISSN] 1048-891X
  • [Journal-full-title] International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
  • [ISO-abbreviation] Int. J. Gynecol. Cancer
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents, Hormonal; 094ZI81Y45 / Tamoxifen
  •  go-up   go-down


74. Dinas K, Daniilidis A, Drizis E, Zaraboukas T, Tzafettas J: Incidental diagnosis of atypical polypoid adenomyoma in a young infertile woman. Eur J Gynaecol Oncol; 2009;30(6):701-3
MedlinePlus Health Information. consumer health - Uterine Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The differential diagnosis of APA includes complex endometrial hyperplasia with atypia, invasive adenocarcinoma, adenofibroma, adenosarcoma and carcinosarcoma.

  • MedlinePlus Health Information. consumer health - Female Infertility.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20099510.001).
  • [ISSN] 0392-2936
  • [Journal-full-title] European journal of gynaecological oncology
  • [ISO-abbreviation] Eur. J. Gynaecol. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


75. McCluggage WG: My approach to the interpretation of endometrial biopsies and curettings. J Clin Pathol; 2006 Aug;59(8):801-12

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Topics such as endometritis, endometrial polyps, changes that are induced by hormones and tamoxifen within the endometrium, endometrial metaplasias and hyperplasias, atypical polypoid adenomyoma, adenofibroma, adenosarcoma, histological types of endometrial carcinoma and grading of endometrial carcinomas are discussed with regard to endometrial biopsy specimens rather than hysterectomy specimens.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Pathol. 2001 Jun;54(6):435-40 [11376015.001]
  • [Cites] Mod Pathol. 2001 Sep;14(9):877-9 [11557783.001]
  • [Cites] Am J Surg Pathol. 2001 Nov;25(11):1347-54 [11684950.001]
  • [Cites] Am J Obstet Gynecol. 2002 Apr;186(4):651-7 [11967486.001]
  • [Cites] Adv Anat Pathol. 2002 May;9(3):145-84 [11981113.001]
  • [Cites] J Clin Pathol. 2002 May;55(5):321-5 [11986333.001]
  • [Cites] J Clin Pathol. 2002 May;55(5):326-31 [11986334.001]
  • [Cites] J Natl Cancer Inst. 1994 Apr 6;86(7):527-37 [8133536.001]
  • [Cites] Int J Gynecol Pathol. 1994 Jul;13(3):248-58 [7928058.001]
  • [Cites] Gynecol Oncol. 1994 Nov;55(2):164-8 [7959278.001]
  • [Cites] J Clin Pathol. 1994 Sep;47(9):827-33 [7962652.001]
  • [Cites] Cancer. 1995 Jan 1;75(1):81-6 [7804981.001]
  • [Cites] Am J Surg Pathol. 1995 Apr;19(4):417-32 [7694943.001]
  • [Cites] J Natl Cancer Inst. 1995 May 3;87(9):645-51 [7752269.001]
  • [Cites] Int J Gynecol Pathol. 1999 Jul;18(3):220-5 [12090590.001]
  • [Cites] Int J Gynecol Pathol. 2002 Oct;21(4):383-90 [12352187.001]
  • [Cites] Int J Gynecol Cancer. 2002 Nov-Dec;12(6):687-90 [12445244.001]
  • [Cites] J Clin Pathol. 2003 Apr;56(4):305-7 [12663645.001]
  • [Cites] Mod Pathol. 2003 Apr;16(4):395-8 [12692205.001]
  • [Cites] Hum Pathol. 1995 Nov;26(11):1260-7 [7590702.001]
  • [Cites] Int J Gynecol Pathol. 1995 Jul;14(3):191-7 [8600069.001]
  • [Cites] Gynecol Oncol. 1996 May;61(2):167-74 [8626128.001]
  • [Cites] Int J Gynecol Pathol. 1996 Jul;15(3):222-9 [8811383.001]
  • [Cites] Int J Gynecol Pathol. 1997 Jan;16(1):33-7 [8986530.001]
  • [Cites] Eur J Obstet Gynecol Reprod Biol. 1997 Apr;72(2):175-80 [9134398.001]
  • [Cites] Br J Obstet Gynaecol. 1997 Jun;104(6):748-50 [9197885.001]
  • [Cites] Obstet Gynecol. 1997 Sep;90(3):434-40 [9277658.001]
  • [Cites] Hum Pathol. 1998 Jun;29(6):551-8 [9635673.001]
  • [Cites] Am J Surg Pathol. 1998 Aug;22(8):1012-9 [9706982.001]
  • [Cites] Int J Gynecol Pathol. 1998 Oct;17(4):302-11 [9785130.001]
  • [Cites] Int J Gynecol Pathol. 1999 Apr;18(2):130-7 [10202670.001]
  • [Cites] Histopathology. 1999 Jul;35(1):44-9 [10383713.001]
  • [Cites] Am J Surg Pathol. 1999 Sep;23(9):1102-8 [10478671.001]
  • [Cites] Histopathology. 2004 Dec;45(6):625-32 [15569054.001]
  • [Cites] J Clin Pathol. 2005 Jan;58(1):1-6 [15623473.001]
  • [Cites] Mod Pathol. 2005 Jan;18(1):75-82 [15389257.001]
  • [Cites] Mod Pathol. 2005 Mar;18(3):324-30 [15529181.001]
  • [Cites] Am J Surg Pathol. 2005 Mar;29(3):295-304 [15725797.001]
  • [Cites] J Clin Pathol. 2005 Apr;58(4):417-9 [15790709.001]
  • [Cites] Hum Pathol. 2003 Sep;34(9):939-43 [14562291.001]
  • [Cites] Adv Anat Pathol. 2003 Nov;10(6):301-18 [14581820.001]
  • [Cites] Int J Gynecol Pathol. 2004 Apr;23(2):129-37 [15084841.001]
  • [Cites] Adv Anat Pathol. 2004 May;11(3):162-71 [15096730.001]
  • [Cites] Am J Surg Pathol. 2004 Aug;28(8):1057-62 [15252313.001]
  • [Cites] Arch Pathol Lab Med. 2004 Sep;128(9):1000-3 [15335255.001]
  • [Cites] Am J Surg Pathol. 1980 Dec;4(6):525-42 [7212146.001]
  • [Cites] Cancer. 1981 Jul 15;48(2):354-66 [6263458.001]
  • [Cites] Am J Surg Pathol. 1981 Jul;5(5):473-82 [7282995.001]
  • [Cites] Cancer. 1982 Jun 15;49(12):2547-59 [7074572.001]
  • [Cites] Gynecol Oncol. 1983 Feb;15(1):10-7 [6822361.001]
  • [Cites] Am J Surg Pathol. 1984 Sep;8(9):719-20 [6476198.001]
  • [Cites] Cancer. 1985 Jul 15;56(2):403-12 [4005805.001]
  • [Cites] J Clin Pathol. 1985 Jun;38(6):644-52 [3891790.001]
  • [Cites] Am J Clin Pathol. 1986 Aug;86(2):139-45 [3739968.001]
  • [Cites] Am J Pathol. 1987 Apr;127(1):66-73 [3565538.001]
  • [Cites] Int J Gynecol Pathol. 1988;7(3):225-35 [3182169.001]
  • [Cites] Lancet. 1989 Feb 18;1(8634):375 [2563519.001]
  • [Cites] Int J Gynecol Pathol. 1989;8(2):125-31 [2714930.001]
  • [Cites] Am J Clin Pathol. 1989 Jun;91(6):664-72 [2543209.001]
  • [Cites] Mod Pathol. 1990 Mar;3(2):120-8 [2326248.001]
  • [Cites] Am J Obstet Gynecol. 1992 Sep;167(3):667-74 [1530020.001]
  • [Cites] J Clin Oncol. 1993 Mar;11(3):485-90 [8383191.001]
  • [Cites] Am J Clin Pathol. 1993 Jun;99(6):741-5 [8322711.001]
  • [Cites] Int J Gynecol Pathol. 1999 Oct;18(4):293-6 [10542935.001]
  • [Cites] Int J Gynecol Pathol. 1999 Oct;18(4):304-9 [10542937.001]
  • [Cites] Mod Pathol. 1999 Dec;12(12):1137-42 [10619266.001]
  • [Cites] Cancer. 2000 Feb 15;88(4):814-24 [10679651.001]
  • [Cites] Gynecol Oncol. 2000 Mar;76(3):287-90 [10684697.001]
  • [Cites] J Pathol. 2000 Mar;190(4):462-9 [10699996.001]
  • [Cites] Am J Surg Pathol. 2000 Jun;24(6):797-806 [10843281.001]
  • [Cites] BJOG. 2000 Oct;107(10):1312-4 [11028588.001]
  • (PMID = 16873562.001).
  • [ISSN] 0021-9746
  • [Journal-full-title] Journal of clinical pathology
  • [ISO-abbreviation] J. Clin. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Number-of-references] 80
  • [Other-IDs] NLM/ PMC1860448
  •  go-up   go-down


76. Garuti G, Cellani F, Centinaio G, Montanari G, Nalli G, Luerti M: Prospective endometrial assessment of breast cancer patients treated with third generation aromatase inhibitors. Gynecol Oncol; 2006 Nov;103(2):599-603
Hazardous Substances Data Bank. TAMOXIFEN .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In 3 patients, the abnormality consisted of simple hyperplasias and in all these patients an abnormal endometrium (1 complex atypical hyperplasia and 2 simple hyperplasias) was already detected at baseline assessment.
  • Only in 1 patient (2.2%) of group 2 did we find an emerging pathology, consisting of adenosarcoma harbored within an endometrial polyp, detected after 12 months of therapy with letrozole.

  • Genetic Alliance. consumer health - Endometrial cancer.
  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16750259.001).
  • [ISSN] 0090-8258
  • [Journal-full-title] Gynecologic oncology
  • [ISO-abbreviation] Gynecol. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Aromatase Inhibitors; 094ZI81Y45 / Tamoxifen
  •  go-up   go-down


77. Simşek S, Belen D, Yiğitkanli K, Aciduman A, Bavbek M: Circumferential total resection of cervical tumors: report of two consecutive cases and technical note. Turk Neurosurg; 2009 Apr;19(2):153-8
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Two cases of subaxial cervical malignancy, one with primary C3 chondrosarcoma and the other with C4 lung adenosarcoma metastasis, were both treated by the anterior-posterior approach.

  • MedlinePlus Health Information. consumer health - Neck Injuries and Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19431126.001).
  • [ISSN] 1019-5149
  • [Journal-full-title] Turkish neurosurgery
  • [ISO-abbreviation] Turk Neurosurg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Technical Report
  • [Publication-country] Turkey
  •  go-up   go-down


78. Kildal W, Abeler VM, Kristensen GB, Jenstad M, Thoresen SØ, Danielsen HE: The prognostic value of DNA ploidy in a total population of uterine sarcomas. Ann Oncol; 2009 Jun;20(6):1037-41
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: In univariate analyses, we observed significantly better crude survival for endometrial stromal sarcomas (ESS) and adenosarcoma (AS) patients with diploid as compared with nondiploid tumors, but not for patients with leiomyosarcomas (LMS).

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19201782.001).
  • [ISSN] 1569-8041
  • [Journal-full-title] Annals of oncology : official journal of the European Society for Medical Oncology
  • [ISO-abbreviation] Ann. Oncol.
  • [Language] ENG
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


79. Lax S: [Mesenchymal uterine tumors. Stromal tumors and other rare mesenchymal neoplasms]. Pathologe; 2009 Jul;30(4):284-91
MedlinePlus Health Information. consumer health - Uterine Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Adenosarcomas are mixed neoplasms with a low grade stromal sarcoma component containing benign glands, which are surrounded by condensed neoplastic stroma.

  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Pathol. 2007 Oct;60(10):1148-54 [17182656.001]
  • [Cites] Am J Clin Pathol. 1976 Sep;66(3):512-25 [961630.001]
  • [Cites] J Mol Diagn. 2005 Aug;7(3):388-95 [16049311.001]
  • [Cites] Virchows Arch. 2004 May;444(5):410-4 [15007645.001]
  • [Cites] Am J Surg Pathol. 1995 Jul;19(7):757-68 [7793473.001]
  • [Cites] Int J Gynecol Pathol. 2008 Apr;27(2):229-35 [18317219.001]
  • [Cites] Histopathology. 1981 Jan;5(1):1-10 [7216172.001]
  • [Cites] Adv Anat Pathol. 2004 May;11(3):162-71 [15096730.001]
  • [Cites] J Clin Pathol. 2007 Mar;60(3):235-43 [17347285.001]
  • [Cites] Am J Surg Pathol. 2008 Aug;32(8):1228-38 [18580489.001]
  • [Cites] Am J Surg Pathol. 1998 Aug;22(8):997-1005 [9706980.001]
  • [Cites] Histopathology. 2009 Feb;54(3):355-64 [19236512.001]
  • [Cites] Int J Gynaecol Obstet. 2009 Mar;104(3):177-8 [19135669.001]
  • [Cites] Adv Anat Pathol. 2004 Nov;11(6):310-5 [15505532.001]
  • [Cites] Int J Gynecol Cancer. 2005 Mar-Apr;15(2):337-42 [15823122.001]
  • [Cites] Pathology. 2007 Feb;39(1):46-54 [17365822.001]
  • [Cites] Am J Surg Pathol. 2009 Feb;33(2):278-88 [18941402.001]
  • (PMID = 19495764.001).
  • [ISSN] 1432-1963
  • [Journal-full-title] Der Pathologe
  • [ISO-abbreviation] Pathologe
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


80. Haberal A, Cil AP, Gunes M, Cavusoglu D: Papillary adenofibroma of the cervix: a case report. Ultrasound Obstet Gynecol; 2005 Aug;26(2):186-7
International Agency for Research on Cancer - Screening Group. diagnostics - A practical manual on visual screening for cervical neoplasia .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • This lesion appears to be clinically and histologically benign but must be differentiated from malignant lesions of the uterus, particularly from adenosarcoma, which can be suggestive of adenofibroma.

  • MedlinePlus Health Information. consumer health - Cervical Cancer.
  • International Agency for Research on Cancer - Screening Group. diagnostics - Histopathology and cytopathology of the uterine cervix - digital atlas .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2005 ISUOG. Published by John Wiley & Sons, Ltd.
  • (PMID = 16041681.001).
  • [ISSN] 0960-7692
  • [Journal-full-title] Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
  • [ISO-abbreviation] Ultrasound Obstet Gynecol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


81. Yalman D, Ozsaran Z, Baltalarli B, Demir O, Ozdemir N, Aras A: Results of postoperative radiotherapy in the treatment of uterine sarcomas: a retrospective analysis of 46 patients. Eur J Gynaecol Oncol; 2008;29(1):46-51
MedlinePlus Health Information. consumer health - Uterine Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • There were 21 mixed mullerian tumors, 12 leiomyosarcomas, 11 endometrial stromal sarcomas and two adenosarcomas.
  • Five-year overall, disease-free and local recurrence-free survival rates were 57.8%, 60.5% and 97.8%, respectively.
  • Prognostic factors influencing disease-free survival were stage (p = 0.009), positive peritoneal cytology (p = 0.000) and the use of chemotherapy (p = 0.002).
  • [MeSH-minor] Adult. Aged. Disease-Free Survival. Female. Humans. Hysterectomy. Kaplan-Meier Estimate. Middle Aged. Ovariectomy. Retrospective Studies

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18386463.001).
  • [ISSN] 0392-2936
  • [Journal-full-title] European journal of gynaecological oncology
  • [ISO-abbreviation] Eur. J. Gynaecol. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


82. Caceres A, Mourton SM, Bochner BH, Gerst SR, Liu L, Alektiar KM, Kardos SV, Barakat RR, Boland PJ, Chi DS: Extended pelvic resections for recurrent uterine and cervical cancer: out-of-the-box surgery. Int J Gynecol Cancer; 2008 Sep-Oct;18(5):1139-44
International Agency for Research on Cancer - Screening Group. diagnostics - A practical manual on visual screening for cervical neoplasia .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Primary sites of disease were the uterus (11 patients) and cervix (3 patients).
  • Tumor histology was as follows: adenocarcinoma, seven; squamous cell carcinoma, three; leiomyosarcoma, three; and adenosarcoma, one.
  • At a median follow-up of 26 months (range, 5-84 months), ten patients (71%) are alive and four patients (29%) have died of disease at 8, 13, 33, and 42 months postoperatively.


83. Lopez-Garcia MA, Palacios J: Pathologic and molecular features of uterine carcinosarcomas. Semin Diagn Pathol; 2010 Nov;27(4):274-86
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Although the diagnosis of UCS is not difficult in most cases, the differential diagnosis may include entities such as undifferentiated or dedifferentiated carcinoma, endometrioid adenocarcinoma with spindle cell elements, sarcomatous overgrowth in a low-grade müllerian adenosarcoma, and pure malignant mesenchymal tumors.

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21309261.001).
  • [ISSN] 0740-2570
  • [Journal-full-title] Seminars in diagnostic pathology
  • [ISO-abbreviation] Semin Diagn Pathol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  •  go-up   go-down


84. Tahlan A, Nanda A, Mohan H: Uterine adenomyoma: a clinicopathologic review of 26 cases and a review of the literature. Int J Gynecol Pathol; 2006 Oct;25(4):361-5
MedlinePlus Health Information. consumer health - Uterine Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Adenomyomas have to be distinguished from a number of other lesions, for example, adenomyosis, leiomyoma with entrapped glands, atypical polypoid adenomyoma, endometrial polyps, adenofibroma, and adenosarcoma.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16990713.001).
  • [ISSN] 0277-1691
  • [Journal-full-title] International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
  • [ISO-abbreviation] Int. J. Gynecol. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 15
  •  go-up   go-down


85. Han XY, Xiang Y, Guo LN, Shen K, Wan XR, Huang HF, Pan LY: Clinicopathological analysis of mullerian adenosarcoma of the uterus. Chin Med J (Engl); 2010 Mar 20;123(6):756-9
MedlinePlus Health Information. consumer health - Uterine Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Clinicopathological analysis of mullerian adenosarcoma of the uterus.
  • [MeSH-major] Adenosarcoma / pathology. Mixed Tumor, Mullerian / pathology. Uterine Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20368100.001).
  • [ISSN] 0366-6999
  • [Journal-full-title] Chinese medical journal
  • [ISO-abbreviation] Chin. Med. J.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] China
  •  go-up   go-down


86. Jha P, Ansari C, Coakley FV, Wang ZJ, Yeh BM, Rabban J, Poder L: Case report: Imaging of Mullerian adenosarcoma arising in adenomyosis. Clin Radiol; 2009 Jun;64(6):645-8
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Case report: Imaging of Mullerian adenosarcoma arising in adenomyosis.
  • [MeSH-major] Adenosarcoma / diagnosis. Endometriosis / diagnosis. Mixed Tumor, Mullerian / diagnosis. Pelvic Neoplasms / diagnosis

  • Genetic Alliance. consumer health - Adenomyosis.
  • MedlinePlus Health Information. consumer health - Endometriosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19414090.001).
  • [ISSN] 1365-229X
  • [Journal-full-title] Clinical radiology
  • [ISO-abbreviation] Clin Radiol
  • [Language] eng
  • [Grant] United States / NIBIB NIH HHS / EB / 1 T32 EB001631
  • [Publication-type] Case Reports; Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Contrast Media
  •  go-up   go-down


87. Tjalma WA, Michener CM: Mullerian adenosarcoma of the uterus associated with long-term oral contraceptive use. Eur J Obstet Gynecol Reprod Biol; 2005 Apr 1;119(2):253-4
MedlinePlus Health Information. consumer health - Uterine Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mullerian adenosarcoma of the uterus associated with long-term oral contraceptive use.
  • [MeSH-major] Adenosarcoma / chemically induced. Contraceptives, Oral / adverse effects. Mullerian Ducts. Uterine Neoplasms / chemically induced

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15808391.001).
  • [ISSN] 0301-2115
  • [Journal-full-title] European journal of obstetrics, gynecology, and reproductive biology
  • [ISO-abbreviation] Eur. J. Obstet. Gynecol. Reprod. Biol.
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] Ireland
  • [Chemical-registry-number] 0 / Contraceptives, Oral
  •  go-up   go-down


88. Limaïem F, Bouraoui S, Azouz H, Lahmar A, Ben Fadhel C, Zouari F, Mzabi-Regaya S: [Adenosarcoma of the cervix with heterologous elements masquerading as a benign polyp: case report]. Tunis Med; 2008 Jul;86(7):725-6
International Agency for Research on Cancer - Screening Group. diagnostics - Histopathology and cytopathology of the uterine cervix - digital atlas .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Adenosarcoma of the cervix with heterologous elements masquerading as a benign polyp: case report].
  • [MeSH-major] Adenosarcoma / pathology. Uterine Cervical Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Cervical Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19472748.001).
  • [ISSN] 0041-4131
  • [Journal-full-title] La Tunisie médicale
  • [ISO-abbreviation] Tunis Med
  • [Language] fre
  • [Publication-type] Case Reports; Letter
  • [Publication-country] Tunisia
  •  go-up   go-down


89. Huang RH, Chu PY, Yeh KT, Hsu JC: Endometrial adenosarcoma. Taiwan J Obstet Gynecol; 2008 Sep;47(3):343-5

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Endometrial adenosarcoma.
  • [MeSH-major] Adenosarcoma / pathology. Adenosarcoma / surgery. Endometrial Neoplasms / pathology. Endometrial Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18936003.001).
  • [ISSN] 1875-6263
  • [Journal-full-title] Taiwanese journal of obstetrics & gynecology
  • [ISO-abbreviation] Taiwan J Obstet Gynecol
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] China
  •  go-up   go-down


90. Giarenis I, Peat D, Nieto JJ: Combined malignant ovarian tumour consisting of angiosarcoma, adenosarcoma, cystadenofibroma and granulosa cell tumour. J Obstet Gynaecol; 2008 Jan;28(1):121-3
MedlinePlus Health Information. consumer health - Ovarian Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Combined malignant ovarian tumour consisting of angiosarcoma, adenosarcoma, cystadenofibroma and granulosa cell tumour.
  • [MeSH-minor] Adenofibroma / diagnosis. Adenofibroma / pathology. Adenofibroma / surgery. Adenosarcoma / diagnosis. Adenosarcoma / pathology. Adenosarcoma / surgery. Diagnosis, Differential. Fatal Outcome. Female. Granulosa Cell Tumor / diagnosis. Granulosa Cell Tumor / pathology. Granulosa Cell Tumor / surgery. Hemangiosarcoma / diagnosis. Hemangiosarcoma / pathology. Hemangiosarcoma / surgery. Humans. Hysterectomy. Middle Aged. Ovariectomy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18259926.001).
  • [ISSN] 1364-6893
  • [Journal-full-title] Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology
  • [ISO-abbreviation] J Obstet Gynaecol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


91. Yang F, Yang KX, Yao XY, Gong J, Song B: [Adenosarcoma arising in abdominal scar endometriosis: report of a case]. Zhonghua Bing Li Xue Za Zhi; 2008 Sep;37(9):643-4
MedlinePlus Health Information. consumer health - Scars.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Adenosarcoma arising in abdominal scar endometriosis: report of a case].
  • [MeSH-major] Abdominal Injuries / complications. Adenosarcoma / etiology. Cicatrix / complications. Endometriosis / complications

  • Genetic Alliance. consumer health - Endometriosis.
  • MedlinePlus Health Information. consumer health - Endometriosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19094594.001).
  • [ISSN] 0529-5807
  • [Journal-full-title] Zhonghua bing li xue za zhi = Chinese journal of pathology
  • [ISO-abbreviation] Zhonghua Bing Li Xue Za Zhi
  • [Language] chi
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] China
  •  go-up   go-down


92. Han X, Leng J, Guo L, Xiang Y, Lang J: Vaginal adenosarcoma arising from refractory endometriosis: a case report. Aust N Z J Obstet Gynaecol; 2010 Dec;50(6):574-6
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Vaginal adenosarcoma arising from refractory endometriosis: a case report.
  • [MeSH-major] Adenosarcoma / etiology. Endometriosis / complications. Vaginal Neoplasms / etiology

  • Genetic Alliance. consumer health - Endometriosis.
  • MedlinePlus Health Information. consumer health - Endometriosis.
  • MedlinePlus Health Information. consumer health - Vaginal Cancer.
  • Hazardous Substances Data Bank. BLEOMYCIN .
  • Hazardous Substances Data Bank. CIS-DIAMINEDICHLOROPLATINUM .
  • Hazardous Substances Data Bank. ETOPOSIDE .
  • Hazardous Substances Data Bank. IFOSFAMIDE .
  • Hazardous Substances Data Bank. EPIRUBICIN .
  • Hazardous Substances Data Bank. VINCRISTINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21133871.001).
  • [ISSN] 1479-828X
  • [Journal-full-title] The Australian & New Zealand journal of obstetrics & gynaecology
  • [ISO-abbreviation] Aust N Z J Obstet Gynaecol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Australia
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / CA-125 Antigen; 0 / MUC16 protein, human; 0 / Membrane Proteins; 11056-06-7 / Bleomycin; 11116-32-8 / bleomycetin; 1421533RCM / Gestrinone; 3Z8479ZZ5X / Epirubicin; 5J49Q6B70F / Vincristine; 6PLQ3CP4P3 / Etoposide; Q20Q21Q62J / Cisplatin; UM20QQM95Y / Ifosfamide
  •  go-up   go-down


93. Chen YL, Hsiao SM, Lin MC, Lin HH: Bone metastasis as the initial presentation in one case of ovarian cancer with two components of endometrioid adenocarcinoma and adenosarcoma. Taiwan J Obstet Gynecol; 2009 Sep;48(3):298-301
MedlinePlus Health Information. consumer health - Ovarian Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Bone metastasis as the initial presentation in one case of ovarian cancer with two components of endometrioid adenocarcinoma and adenosarcoma.
  • [MeSH-major] Adenosarcoma / secondary. Bone Neoplasms / secondary. Carcinoma, Endometrioid / secondary. Neoplasms, Second Primary / secondary. Ovarian Neoplasms / pathology

  • Genetic Alliance. consumer health - Ovarian cancer.
  • Genetic Alliance. consumer health - Bone Cancer.
  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19797025.001).
  • [ISSN] 1875-6263
  • [Journal-full-title] Taiwanese journal of obstetrics & gynecology
  • [ISO-abbreviation] Taiwan J Obstet Gynecol
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] China
  •  go-up   go-down






Advertisement